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Abstract	  
The	  skin	  is	  a	  remarkable	  barrier,	  protecting	  us	  from	  invasion	  of	  e.g.	  harmful	  microorganisms	  
and	   UV-­‐radiation.	   However,	   the	   skin	   is	   not	   adopted	   to	   resist	   repeated	   exposure	   to	   the	  
multitude	  of	  xenobiotics	  introduced	  into	  modern	  society.	  Some	  of	  these	  chemicals	  are	  skin	  
sensitizers,	   and	   exposure	   can	   lead	   to	   the	   development	   of	   contact	   allergy.	   Contact	   allergy	  
has	  significant	  social	  and	  economic	  consequences,	  both	  for	  the	  individual	  and	  for	  society.	  It	  
is	   therefore	   important	   to	  prevent	  sensitization.	  The	  skin	  also	  constitutes	  a	  potential	   route	  
for	  administration	  of	  drugs,	  and	  much	  effort	  is	  put	  into	  the	  development	  of	  cutaneous	  and	  
transdermal	  drug	  delivery	  systems.	  	  
The	   work	   of	   this	   thesis	   aims	   to	   improve	   the	   understanding	   of	   processes	   related	   to	   the	  
interactions	   between	   the	   skin	   and	   topically	   applied	   compounds,	   i.e.	   drugs	   and	   skin	  
sensitizers.	   Specifically,	   two-­‐photon	   microscopy	   has	   been	   used	   to	   study	   the	   cutaneous	  
absorption	  and	  distribution	  of	  model	  drugs	  and	  a	  series	  of	  model	  skin	  sensitizers.	  	  
Improved	   cutaneous	   absorption	   was	   demonstrated	   using	   formulations	   composed	   of	   lipid	  
cubic	  phases.	  The	  work	  also	   showed	  elevated	   sensitization	  potency	  of	  haptens	  depending	  
on	  delivery	  vehicles.	  Putative	  mechanistic	  explanations	  for	  the	  observed	  effects	  have	  been	  
proposed.	   Specifically,	   phthalates	   were	   shown	   to	   increase	   the	   sensitization	   potency	   of	  
isothiocyanates.	  The	  phthalate-­‐induced	  effect	  could	  be	  linked	  to	  a	  PSU-­‐targeted	  delivery	  of	  
the	   haptens	   into	   the	   skin.	   It	   could	   also	   be	   shown	   that	   vehicles	   alter	   hapten	   reactivity	   to	  
stratum	  corneum	  proteins	  leading	  to	  variations	  in	  sensitization	  potency.	  Moreover,	  hapten	  
protein	   targets	   in	   skin	   have	   been	   identified	   using	   caged	   fluorescent	   model	   hapten.	  
Specifically,	   basal	   cell	   keratinocytes	   and	   the	   keratins	   were	   identified	   as	   specific	   hapten	  
targets	  in	  the	  skin.	  
In	  conclusion,	  the	  work	  presented	  in	  this	  thesis	  contributes	  to	  the	  general	  understanding	  of	  
the	  mechanisms	   involved	   in	   the	   cutaneous	   absorption	   of	   topically	   applied	   drugs	   and	   skin	  
sensitizers.	   It	   also	   demonstrates	   the	   capabilities	   of	   using	   TPM	   when	   investigating	   the	  
interactions	  between	  the	  skin	  and	  xenobiotics.	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1 Introduction	  
	  
All	  living	  organisms	  have	  an	  outer	  protective	  surface	  separating	  endogenous	  and	  exogenous	  
compartments.	  The	  human	  skin,	  a	  keratinized	  stratified	  squamous	  epithelium,	  incorporates	  
a	  multitude	  of	  vital	  physical	  and	  biological	  functions.	  One	  of	  the	  key	  functions	  of	  the	  skin	  is	  
to	   protect	   the	   living	   interior	   compartments	   of	   the	   body	   from	   invasion	   by	   pathogenic	  
microorganisms	  and	  harmful	  UV-­‐radiation	  [1].	  	  
However,	  the	  barrier	   is	  not	  foolproof,	  e.g.	   it	   is	  not	  evolutionary	  fit	  to	  handle	  the	  repeated	  
exposures	   to	   many	   of	   the	   now	   frequently	   occurring	   more	   or	   less	   toxic	   environmental	  
xenobiotics,	   which	   have	   been	   introduced	   into	   modern	   society.	   Chemicals	   are	   constantly	  
invading	  the	  skin	  and	  the	  body.	  One	  of	  the	  consequences	  thereof	  has	  been	  an	   increase	   in	  
the	   manifestation	   of	   contact	   allergy,	   today	   affecting	   approximately	   15-­‐20	   %	   of	   the	  
population	   in	  the	  western	  world	  [2].	  Preventive	  work	   is	   important	  as	  contact	  allergy	  often	  
has	   significant	   socio-­‐economic	   consequences,	   both	   for	   the	   individual	   and	   society;	   e.g.	  
numerous	  cases	  of	  contact	  allergy	  are	  work-­‐related	  and	  often	   lead	  to	   long	  sick-­‐leaves	  and	  
sometimes	  oblige	  the	  patient	  to	  change	  profession.	  
The	   efforts	   to	   reduce	   the	   prevalence	   of	   contact	   allergy	   include	   an	   increase	   of	   the	  
understanding	   of	   the	   mechanisms	   involved	   in	   the	   development	   of	   the	   disease,	   e.g.	   skin	  
absorption,	  chemical	   reactivity,	  biotransformations	  and	   immunological	  mechanisms.	  Much	  
has	  been	  learnt,	  but	  several	  key	  steps	  in	  the	  pathogenesis	  are	  still	  more	  or	  less	  shrouded	  in	  
mystery.	  The	  preventive	  work	  also	  includes	  the	  development	  of	  efficient	  and	  reliable	  tools	  
for	  identification	  of	  allergens,	  removal	  and	  replacement	  of	  identified	  allergenic	  compounds	  
in	   consumer	   products	   and	  development	   of	   ‘safe’	   formulations,	  minimizing	   the	   absorption	  
and	  accumulations	  of	  potentially	  harmful	  components	  in	  ‘non-­‐target’	  tissue.	  	  
However,	   on	   the	   other	   side	   is	   the	   pharmaceutical	   industry,	   struggling	   with	   the	   low	  
permeability	   of	   the	   skin,	   which	   makes	   epicutaneous	   delivery	   of	   drugs	   especially	  
cumbersome.	   Nonetheless	   it	   is	   often	   an	   attractive	   alternative	   to	   oral	   or	   intravenous	  
administration	   and	   much	   effort	   is	   being	   made	   in	   the	   development	   of	   more	   effective	  
formulations,	  optimizing	  the	  absorption	  profile	  depending	  on	  the	  target	  tissue.	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This	   thesis	   includes	   five	   studies,	   dealing	   with	   the	   cutaneous	   uptake	   and	   distribution	   of	  
topically	  applied	  compounds.	  One	  study	  with	  the	  focus	  on	  drug	  delivery,	  specifically	  the	  use	  
of	   liquid	  crystalline	  bicontinuous	  cubic	  phases	   in	  epicutaneous	   formulations	   (Paper	   I),	  and	  
four	   studies	   investigating	   different	   aspects	   regarding	   the	   cutaneous	   absorption	   and	  
distribution	  of	  skin	  sensitizers,	  e.g.	  factors	  affecting	  the	  uptake	  and	  sensitization	  potency	  of	  
haptens	  and	  hapten	  targets	  in	  the	  skin	  (Paper	  II-­‐V).	  Specifically,	  this	  thesis	  highlights	  some	  
of	   the	   advantages	   using	   TPM	   when	   investigating	   the	   interactions	   between	   the	   skin	   and	  
xenobiotics.	  
The	   thesis	   was	   performed	   within	   the	   Centre	   for	   Skin	   Research	   Gothenburg	   (SkinReGU),	  
which	   is	   a	   collaboration	   between	   research	   groups	   at	   the	   Faculty	   of	   Science	   and	   the	  
Sahlgrenska	   Academy	   at	   the	   University	   of	   Gothenburg	   and	   Chalmers	   University	   of	  
Technology.	   It	   comprises	   research	   groups	   within	   the	   fields	   of	   dermatochemistry,	  
dermatology,	  medicinal	  chemistry,	  nanotechnology,	  biophysics,	  physical	  chemistry,	  organic	  
chemistry,	  surface	  chemistry,	  odontology,	  and	  pharmaceutics.	  	  The	  center	  provides	  a	  unique	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2 The	  Skin	  –	  Anatomy	  and	  Function	  
	  
The	  skin,	  or	  the	  integumentary	  system	  (from	  Latin	  tegere	  ‘to	  cover’),	  is	  our	  largest	  organ.	  It	  
has	   a	   surface	   area	   between	   1.2-­‐2.2	  m2,	   an	   average	   thickness	   of	   1.5-­‐4	  mm	  and	  makes	   up	  
approximately	   7%	  of	   the	   total	   body	  weigh	   in	   the	   average	   adult	  man	   [3].	   The	   skin	   can	   be	  
divided	   into	   two	   major	   compartments;	   the	   epidermis,	   an	   avascular	   stratified	   squamous	  
epithelium	  mainly	   composed	   of	   terminally	   differentiating	   keratinocytes	   and	   the	   dermis	   a	  
connective	  tissue	  with	  a	  large	  fraction	  of	  collagen	  and	  elastin	  fibers	  providing	  strength	  and	  
flexibility	  (Figure	  2.1)	  [4].	  	  
	  
	  
Figure	  2.1.	  	  Structure	  of	  the	  skin	  and	  underlying	  subcutaneous	  tissue.	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The	   skin	   can	   be	   regarded	   both	   as	   a	   bridge	   and	   a	   barrier	   between	   our	   body	   and	   the	  
exogenous	  environment.	   It	  upholds	  a	  multitude	  of	  vital	   functions,	  e.g.	   it	  mediates	  sensory	  
perceptions,	   regulates	   body	   temperature	   and	   the	   endogenous	   water	   balance,	   acts	   as	   a	  
blood	  reservoir	  and	  protects	  the	  body	  from	  harmful	  UV-­‐radiation	  and	  physical	  trauma	  [1].	  	  
Another	  key	  function	  of	  the	  skin	  is	  to	  protect	  the	  living	  interior	  compartments	  of	  the	  body	  
from	  invasion	  by	  pathogenic	  microorganisms.	  This	  task	  is	  fulfilled	  via	  the	  collaboration	  of	  a	  
membrane	   like	   physical	   barrier	   (stratum	   corneum),	   a	   biochemical	   barrier	   (e.g.	   hydrolytic	  
enzymes,	  antibacterial	  fatty	  acids	  and	  antimicrobial	  peptides)	  and	  an	  immunological	  barrier	  
involving	  the	  cells	  of	  the	  immune	  systems	  [5].	  Together,	  these	  form	  a	  bio-­‐physicochemical	  
first	  line	  of	  defense,	  which	  would	  be	  impossible	  to	  live	  without.	  This	  chapter	  includes	  a	  brief	  
introduction	  to	   the	  anatomy	  of	   the	  skin,	  with	  a	  specific	   focus	  on	  the	  structures	  related	  to	  
the	  skin	  barrier	  functions.	  	  
2.1 Epidermis	  
2.1.1 Cellular	  composition	  and	  structure	  
Epidermis	  is	  composed	  of	  terminally	  differentiating	  keratinocytes,	  epidermal	  dendritic	  cells	  
or	  Langerhans	  cells,	  melanocytes,	  and	  merkel	  cells	   [4].	  Of	  these,	  the	  keratinocytes	  are	  the	  
most	   abundant	   cell	   type	  making	  up	   approximately	   95%	  of	   the	   epidermal	   volume	   [1].	   The	  
keratinocytes	   forms	   a	   stratified	   squamous	   epithelium,	   generally	   divided	   into	   four	   specific	  
layers	  based	  on	   the	  degree	  of	  cellular	  differentiation,	   i.e.	   the	  stratum	  basale,	   the	  stratum	  
spinousum,	   the	  stratum	  granulosum	  and	  the	  stratum	  corneum	   (Figure	  2.2)	  [6].	  Langerhans	  
cells,	   which	   are	   the	   second	   most	   abundant	   cell	   type	   in	   the	   epidermis,	   are	   professional	  
antigen	  presenting	  cells,	  which	  have	  an	   important	   role	   in	   the	  skin	   immune	  defense	   [7,	  8].	  
Melanocytes	   are	  melanin-­‐producing	   cells	   residing	   in	   the	   basal	   cell	   layer	   [4].	  Melanin	   is	   a	  
pigment	   protecting	   the	   nucleus	   of	   basal	   keratinocytes	   from	   UV-­‐radiation.	   	   Merkel	   cells,	  
which	  also	  reside	   in	  the	  basal	  cell	   layer,	  are	  sensory	  receptor	  cells	  associated	  with	  dermal	  
nerve	  fibers	  [4].	  The	  average	  thickness	  of	  human	  epidermis	  is	  approximately	  75-­‐150	  μm,	  but	  
varies	  significantly	  depending	  on	  the	  body	  site	  [3].	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Figure	  2.2.	  The	  structure	  of	  the	  epidermis,	  comprising	  the	  basal	  membrane,	  stratum	  basale,	  stratum	  spinosum,	  
stratum	  granulosum	  and	  stratum	  corneum.	  Adjacent	  keratinocytes	  are	  connected	  via	  desmosomes,	  which	  bind	  
to	  keratin	  intermediate	  filaments.	  Keratinohyaline	  granules,	  formed	  in	  the	  spinous	  layer,	  contain	  profillagrin	  
which	  aggregates	  the	  keratins	  in	  the	  stratum	  corneum.	  Lamellar	  bodies	  contain	  lipids,	  which	  are	  expelled	  into	  
the	  extracellular	  matrix	  in	  the	  border	  between	  stratum	  granulosum	  and	  stratum	  corneum.	  
	  	  
2.1.2 	  Viable	  epidermis	  
Stratum	   basale,	   spinosum	   and	  granulosum	   are	   the	   living	   layers	   of	   the	   epidermis	   and	   are	  
together	  commonly	  referred	  to	  as	  the	  viable	  epidermis.	  Stratum	  basale	   is	  a	  single	   layer	  of	  
columnar	   shaped	  cells	   connected	   to	   the	  epidermal	  basement	  membrane	   [4].	   It	   includes	  a	  
subpopulation	  of	  mitotic	  epidermal	   stem	  cells	   [9].	  The	  basal	   cells	  undergo	  continuous	  cell	  
divisions	  renewing	  the	  suprabasal	  epidermal	  cell	  populations.	  Stratum	  spinosum,	  is	  a	  five	  to	  
ten	   cell	   layers	   thick	   structure	   composed	   of	   cuboidal	   cells	   and	   stratum	   granulosum	   is	  
composed	  of	  two	  to	  three	  layers	  of	  squamous	  cells	  [3].	  Epidermis	  is	  an	  avascular	  epithelium,	  
and	  the	  cells	  are	  dependent	  on	  the	  passive	  diffusive	  flow	  of	  nutrients	  from	  the	  capillaries	  in	  
dermis.	   The	   keratinocytes	   in	   viable	   epidermis	   are	   interconnected	   via	   desmosomes,	  
adherence	  junctions,	  gap	  junctions	  and	  tight	  junctions	  [1].	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2.1.3 Stratum	  corneum	  
Stratum	   corneum	   is	   an	   approximately	   16-­‐20	   µm	   thick	   layer	   of	   dead	   keratinocytes	   or	  
corneocytes,	  embedded	  in	  a	  matrix	  of	  lamellar	  lipid	  bilayers	  [6].	  It	  is	  commonly	  compared	  to	  
a	  brick	  wall	  protecting	  the	  viable	  endogenous	  compartments.	  	  
The	   bricks	   (corneocytes)	   are	   40-­‐50	   μm	   broad	   and	   1	   μm	   thick,	   hexagonal,	   scale-­‐like	   cells	  
formed	  by	  the	  terminally	  differentiating	  keratinocytes,	  in	  a	  type	  of	  programmed	  cell	  death	  
commonly	   referred	   to	   as	   cornification	   [10,	   11].	   Briefly,	   as	   the	   proliferating	   basal	  
keratinocytes	  are	  detached	  from	  the	  basal	  membrane	  and	  move	  up	  into	  the	  spinous	  layer,	  
the	  cells	  starts	  to	  synthesize	  new	  sets	  of	  structural	  proteins,	  of	  which	  some	  becomes	  cross-­‐
linked	  beneath	   the	  plasma	  membrane.	  Cross-­‐linking	  of	  proteins	  under	   the	  cell	  membrane	  
continuous	   up	   in	   the	   granular	   layer,	   building	   an	   insoluble	   protein	   polymer	   called	   the	  
cornified	   envelope.	   	   Concurrently,	   profillagrin,	   originating	   from	   keratohyalin	   granules	  
formed	  in	  the	  spinous	  layer	  decomposes	  into	  fillagrin,	  which	  aggregates	  and	  cross-­‐links	  the	  
keratins	   forming	   insoluble	   intracellular	  macro-­‐fibers,	  which	  are	   covalently	  attached	   to	   the	  
cornified	  envelope.	  The	  corneocytes	  are	  continuously	  exfoliated	  or	  desquamated	  at	  the	  skin	  
surface	  and	  the	  epidermis	  is	  completely	  renewed	  every	  25-­‐45	  days	  [3].	  	  
The	  mortar	   is	  composed	  of	  a	  matrix	  of	  polar	   lipids,	  mainly	  ceramides	  (45-­‐50	  %),	   free	  fatty	  
acids	   (10-­‐15	  %)	   and	   cholesterol	   (25	  %)	   [11-­‐14].	   These	   are	   synthesized	   from	   phospholipid	  
precursors	   in	   lamellar	   bodies,	   originating	   from	   the	   Golgi,	   which	   fuses	   with	   the	   plasma	  
membrane	   in	   the	  border	  between	   the	  granular	   layer	  and	  stratum	  corneum.	  The	   lipids	  are	  
organized	  in	  multi-­‐lamellar	  lipid	  bilayers	  with	  alternating	  lipophilic	  and	  hydrophilic	  domains	  
(Figure	   2.1),	   stabilized	   via	   hydrophilic	   interactions	   between	   the	   polar	   head-­‐groups	   and	  
hydrophobic	  interactions	  between	  the	  long,	  straight,	  aliphatic	  tails	  of	  the	  ceramides	  and	  the	  
free	  fatty	  acids.	  A	  fraction	  of	  the	  ceramides	  content	  is	  also	  covalently	  attached	  to	  cornified	  
envelope	   forming	   a	   lipid	   envelope	   strengthening	   the	   cornified	   envelop	   [10].	   The	   lipid	  
fraction	   is	   of	   major	   importance	   for	   the	   skin	   barrier,	   e.g.	   diseases	   affecting	   the	   lipid	  
composition	   and	   structure	   of	   stratum	   corneum	   have	   been	   shown	   to	   alter	   the	   barrier	  
properties	  of	  the	  skin	  [13].	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2.1.4 Keratins	  
Keratin	  is	  the	  main	  structural	  protein	  of	  the	  keratinocytes	  and	  the	  most	  abundant	  protein	  in	  
the	   epidermis	   [15,	   16].	   Keratins	   assembled	   into	   fibrous	   structures	   called	   keratin	  
intermediate	   filaments,	   extending	   between	   the	   nuclear	   lamina	   and	   cell	   membrane	  
associated	   protein	   complexes	   called	   desmosomes	   (Figure	   2.2).	   Keratin	   intermediate	  
filaments	   form	  the	  cytoskeleton	  of	   the	  epidermal	  cells.	  Keratin	   intermediate	   filaments	  are	  
composed	  of	  pairs	  of	  different	  types	  of	  keratins.	  Basal	  cells	  mainly	  express	  pairs	  of	  keratin	  5	  
(K5)	  and	  keratin	  14	  (K14)	  while	  spinous	  and	  granular	  cells	  express	  keratin	  1	  and	  keratin	  10	  
[17-­‐21].	  As	   the	   cell	   progress	  up	   into	   the	   stratum	  corneum,	   keratin	   intermediate	   filaments	  
are	  aggregated	  with	  fillagrin	  leading	  to	  a	  structural	  collapse	  of	  the	  cell	  [22,	  23].	  	  
2.2 Dermis	  
The	  dermis	  is	  a	  connective	  tissue	  separated	  from	  epidermis	  by	  the	  basal	  membrane.	  It	  can	  
be	   divided	   in	   two	   separated	   layers,	   the	   superficial	   papillary	   layer	   and	   the	   underlying	  
reticular	  dermis	   (Figure	  2.1).	  The	  papillary	   layer	   includes	   the	  dermal	  papillae	   forming	  peg-­‐
like	  structures	  penetrating	  the	  epidermis.	  Dermis	  is	  mostly	  composed	  of	  collagen	  and	  elastin	  
fibers	   in	   a	   polysaccharide	  matrix.	   The	   cellular	   fraction	   includes	   fibroblasts,	   macrophages,	  
dermal	  dendritic	  cells	  and	  lymphocytes.	  The	  dermis	  is	  also	  rich	  in	  vascular	  channels	  (blood	  
vessels	  and	  lymphatic	  vessels)	  and	  nerve	  fibers.	  The	  dermis	  is	  attached	  to	  the	  hypodermis,	  
an	   adipose	   tissue,	   which	   connects	   the	   skin	   to	   the	   internal	   body	   structures,	   primarily	   the	  
muscles	  [1,	  4].	  	  
2.3 Skin	  appendages	  
The	  skin	  appendages	  include	  the	  hair	  follicles,	  the	  hair,	  the	  sebaceous	  glands	  and	  the	  sweat	  
glands.	   The	   appendages	   originate	   from	   epidermal	   tissue	   but	   penetrate	   deep	   into	   the	  
reticular	   dermis.	   The	   hair,	   hair	   follicle	   and	   hair	   follicle	   associated	   sebaceous	   glands	   are	  
generally	  referred	  to	  as	  the	  pilosebaceous	  unit	  (PSU).	  The	  PSU	  extend	  all	  the	  way	  down	  to	  
the	   hypodermis.	   In	   human	   skin	   there	   is	   an	   average	   of	   10	   –	   70	   PSUs	   per	   cm2	   covering	  
approximately	   0.1%	  of	   the	   total	   skin	   surface	   in	   the	   average	   adult	  man	   [24].	   The	   PSU	   cell	  
population	  includes	  more	  than	  20	  different	  cell	  types	  and	  it	  has	  a	  relatively	  large	  fraction	  of	  
stem	  cells	  and	  immune	  cells	  e.g.	  Langerhans	  cells,	  T-­‐cells	  and	  macrophages	  [9,	  25-­‐27].	  The	  
follicle	  wall	   is	  composed	  of	  an	  internal	  and	  external	  epithelial	  root	  sheath	  and	  a	  basement	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membrane	   called	   the	   glassy	  membrane	   and	   it	   is	   surrounded	   by	   an	   extensive	   network	   of	  
perifollicular	   capillaries	   [28].	   The	   follicle	   associated	   sebaceous	   glands	   produce	   sebum,	   a	  
mixture	  of	  fatty	  acids,	  which	  are	  secreted	  to	  the	  skin	  surface.	  Sebum	  function	  as	  a	  natural	  
moisturizer	   softening	   the	   skin	   and	   the	   hair.	   It	   is	   also	   a	   bactericidal	   protecting	   against	  
pathogen	  invasion	  [1].	  The	  skin	  appendages	  are	  regions	  of	  partly	  reduced	  skin	  barrier.	  Their	  
implication	   in	   the	   uptake	   of	   topical	   applied	   compounds	   will	   be	   discussed	   further	   in	   the	  
subsequent	  chapters	  of	  this	  thesis.	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3 Contact	  Allergy	  
	  
Contact	  allergy	  is	  a	  T-­‐cell	  mediated	  delayed	  type	  (IV)	  contact	  hypersensitivity	  disease	  caused	  
by	  low	  molecular	  weight	  chemical	  allergens	  called	  haptens	  [29,	  30].	  The	  clinical	  outcome	  of	  
contact	  allergy	  is	  a	  skin	  inflammation	  with	  locally	  confined	  erythema	  and	  oedema	  referred	  
to	  as	  allergic	  contact	  dermatitis	  (ACD)	  [30].	  Contemporary	  lifestyles	  has	  led	  to	  an	  increase	  in	  
the	  public	  exposure	  to	  haptens,	  and	  contact	  allergy	  has	  become	  a	  common	  health	  problem,	  
affecting	   approximately	   15	   -­‐20%	  of	   the	   population	   in	   the	  western	  world	   [2].	  Haptens	   are	  
found	  in	  a	  wide	  variety	  of	  consumer	  products,	  e.g.	  in	  cosmetics	  and	  household	  products	  [31,	  
32].	   Occupational	   related	   exposure	   is	   also	   frequent	   [33,	   34].	   The	   most	   common	   contact	  
allergen	   today	   is	  nickel	   followed	  by	   fragrances	   [32].	  Preservatives	   [35],	  UV-­‐filters	   [36]	  and	  
epoxy	  resins	  [37]	  are	  other	  prevalent	  haptens.	  This	  chapter	  will	  give	  an	  introduction	  to	  the	  
chemical	  and	  immunological	  mechanisms	  in	  ACD,	  methods	  for	  predictive	  testing	  and	  factors	  
affecting	  the	  sensitization	  potency	  of	  haptens.	  Also,	  the	  fluorescent	  model	  haptens	  used	  in	  
this	  thesis	  will	  be	  discussed.	  	  
3.1 Pathogenesis	  
The	   immunological	  mechanisms	   involved	   in	   the	   development	   of	   ACD	   can	   be	   divided	   into	  
two	  phases,	  i.e.	  a	  sensitization	  phase	  and	  an	  elicitation	  phase.	  The	  sensitization	  phase	  is	  the	  
first	   exposure	   to	   a	   hapten	   leading	   to	   a	   priming	   and	  differentiation	  of	   effector	   T-­‐cells	   and	  
immunological	  memory.	  The	  elicitation	  phase	  takes	  place	  upon	  re-­‐exposure	  to	  the	  hapten	  
leading	   to	   a	   hapten-­‐specific	   T-­‐cell	  mediated	   localized	   inflammation	   in	   the	   affected	   tissue	  
(Figure	  3.1).	  
3.1.1 Sensitization	  
The	   sensitization	   phase	   starts	   with	   the	   entry	   of	   hapten	   into	   the	   skin,	   leading	   to	   the	  
formation	  of	   immunogenic	  hapten-­‐protein	  complexes	  and	   the	   release	  of	  proinflammatory	  
cytokines	  by	  the	  cells	  in	  the	  skin	  [38].	  Hapten	  or	  hapten-­‐protein	  complexes	  are	  recognized	  
and	   internalized	   by	   immature	   resident	   epidermal	   and	   dermal	   dendritic	   cells	   or	   recruited	  
dendritic	  cell	  precursors.	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Cytokine	   signalling	   triggers	   a	  migration	   of	   haptenated	   dendritic	   cells	   from	   the	   peripheral	  
tissue	   via	   the	   afferent	   lymphatic	   vessels	   towards	   the	   draining	   lymph	   nodes	   [39-­‐41].	   The	  
signaling	   also	   elicits	   a	   maturation	   of	   the	   dendritic	   cells	   into	   a	   professional	   antigen	  
presenting	   cells	   with	   up-­‐regulated	   expression	   of	  major	   histocompatibility	   complex	   (MHC)	  
and	   co-­‐stimulatory	  molecules.	   Naïve	   T-­‐cells	   home	   to	   the	   deep	   cortical	   unit	   of	   the	   lymph	  
node	   where	   dendritic	   cells	   present	   processed	   hapten-­‐protein	   complexes	   (haptenated	  
peptides)	  on	  the	  surface	  of	  MHC	  molecules	  [42].	  If	  a	  T-­‐cell	  has	  a	  cognate	  T-­‐cell	  receptor	  and	  
co-­‐receptors	  (CD4	  or	  CD8)	  to	  the	  MHC-­‐peptide	  antigen	  complex	  it	  will	  be	  activated	  leading	  
to	   the	   proliferation	   and	   differentiation	   into	   antigen	   specific	   effector	   or	   memory	   T-­‐cells.	  	  
Haptenated	  peptides	  presented	  by	  dendritic	  cells	  on	  the	  surface	  of	  MHC	  class	   I	  molecules	  
activate	   cytotoxic	   T-­‐cells	   expressing	   the	   CD8	   glycoprotein	   co-­‐receptors	   and	   haptenated	  
peptides	   presented	  on	  MHC	   class	   II	  molecules	   activate	   helper	   T-­‐cells	   or	   regulatory	   T-­‐cells	  
expressing	   CD4	   glycoprotein	   co-­‐receptors	   [43].	   Primed	   effector	   T-­‐cells	   leaves	   the	   lymph	  
node	  via	  the	  efferent	   lymphatic	  and	  start	   to	  circulate	  the	  blood,	   the	  peripheral	   tissue	  and	  
the	  peripheral	  lymphoid	  organs.	  Sensitization	  phase	  takes	  approximately	  10-­‐15	  days	  in	  man	  
and	  5-­‐7	  days	  in	  mouse	  [38].	  
	  
3.1.2 Elicitation	  
The	   elicitation	   phase	   begins	   with	   a	   non-­‐specific	   hapten	   induced	   secretion	   of	  
proinflammatory	   chemokines	   and	   cytokines.	   This	   triggers	   and	   an	   up-­‐regulation	   of	   MHC	  
molecules	   on	   the	   keratinocytes	   and	   cutaneous	   dendritic	   cells	   and	   an	   extravasation	   of	  
hapten	  specific	  CD8+	  cytotoxic	  effector	  T-­‐cells.	  The	  infiltrated	  cytotoxic	  T-­‐cells	  are	  activated	  
by	   haptenated	   peptides	   presented	   on	   MHC	   I	   molecules.	   Release	   of	   new	   sets	   of	  
inflammatory	  cytokines,	  leads	  to	  the	  infiltration	  and	  activation	  of	  other	  cells	  of	  the	  immune	  
system,	   e.g.	   neutrophils,	   natural	   killer	   cells	   and	   regulatory	   T-­‐cells	   [38,	   44].	   The	   influx	   of	  
liquids,	   proteins	   and	   cells	   from	   the	   blood	   leads	   to	   a	   local	   erythema	   and	   oedema,	   which	  
generally	  peak	  between	  48-­‐72	  h	  in	  man	  [45]	  and	  24-­‐48	  h	  in	  mouse	  [46].	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Figure	   3.1.	   An	   overview	   of	   the	   events	   during	   the	   sensitization	   and	   elicitation	   phase	   in	   allergic	   contact	  
dermatitis.	   The	   sensitization	   phase	   (a	   and	   b):	   Hapten	   penetrate	   the	   skin	   barrier	   (1)	   and	   interacts	  with	   skin	  
resident	   cells	   and	  proteins	   (2)	   leading	   to	   the	   formation	   of	   immunogenic	   hapten-­‐protein	   complexes	   and	   the	  
release	   of	   proinflammatory	   mediators.	   The	   hapten	   protein	   complexes	   are	   recognized	   and	   internalized	   by	  
immature	  cutaneous	  dendritic	  cells	  (3),	  which	  migrates	  towards	  the	  skin	  draining	  lymph	  nodes	  (4),	  where	  they	  
present	   processed	   hapten-­‐protein	   complexes	   to	   naïve	   T-­‐cells	   (5).	   Activation	   of	   T-­‐cells	   leads	   to	   a	   clonal	  
expansion	   (6)	   of	   effector	   cells,	   which	   leaves	   the	   lymph	   node	   and	   enters	   the	   systemic	   circulation	   (7).	   The	  
elicitation	   phase	   (c):	   Formation	   of	   hapten-­‐protein	   complexes	   and	   release	   of	   proinflammatory	   mediators	  
attracts	   effector	   T-­‐cells	   that	   are	   activated	   by	   skin	   resident	   antigen-­‐presenting	   cells,	   e.g.	   dendritic	   cells	   (2).	  
Further	   releases	   of	   of	   proinflammatory	   mediators	   attract	   other	   leukocytes,	   e.g.	   neutrophils	   and	   NK-­‐cells,	  
which	  amplify	  the	  inflammatory	  reaction	  (3).	  Adopted	  from	  [38].	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3.2 Haptens	  
Haptens	  are	  intrinsically	  too	  small	  to	  be	  recognized	  by	  the	  immune	  system	  and	  to	  cause	  an	  
allergic	   reactions	   [47].	   To	   trigger	   an	   adaptive	   immune	   response,	   hapten	  must	   react	   with	  
endogenous	  macromolecules,	  proteins	  or	  peptides,	  forming	  immunogenic	  non-­‐self	  hapten-­‐
protein	   complexes	   [48].	  Most	   haptens	   are	   electrophiles,	   e.g.	   alkyl	   halides,	   aldehydes,	   αβ-­‐
unsaturated	   ketones,	   esters	   and	   amines,	   hydroperoxides,	   epoxides,	   and	   isothiocyanates	  
[29].	  
Skin	   sensitizers	   are	   believed	   to	   form	   hapten-­‐protein	   complexes	   via	   polar	   reactions	   with	  
nucleophilic	   amino	   acids,	   e.g.	   lysines,	   cysteines,	   histidines,	   methionines	   and	   tyrosines.	  
Examples	  of	  reactions	  which	  could	  be	  relevant,	  are	  bimolecular	  substitutions	  (SN2),	  aromatic	  
substitutions,	  Michael	   additions,	   Schiff	   base	   formations	   and	   acylations	   [29].	   Haptens	   can	  
also	   form	   protein	   complexes	   via	   radical	   reactions	   (e.g.	   hydroperoxides)	   [49]	   or	   through	  
metal-­‐protein	  coordination	  complexes	  (e.g.	  nickel	  and	  chromium)	  [50].	  	  
The	  formation	  of	  immunogenic	  hapten-­‐protein	  complexes	  is	  a	  prerequisite	  for	  activation	  of	  
the	   adaptive	   immune	   system.	   Still,	   some	   non-­‐reactive	   compounds	   also	   cause	   contact	  
allergy.	   These	   are	   referred	   to	   as	   pre-­‐	   or	   prohaptens.	   These	   are	   activated	   to	   reactive	  
allergenic	   intermediates	   (electrophilic	   or	   radical)	   via	   autoxidation	   (prehaptens)	   [51-­‐53]	   or	  
metabolic	  transformations	  (prohaptens)	  [54].	  Examples	  of	  non-­‐reactive	  chemicals	  that	  have	  
been	   found	   to	   form	   reactive	   sensitizing	   intermediates	   are	   aliphatic	   and	   aromatic	   amines,	  
azo	   dyes,	   catechols,	   hydroquinones,	   conjugated	   dienes,	   primary	   alcohols	   and	   αβ-­‐
unsaturated	  oximes	  [29,	  55].	  	  
In	  this	  thesis	  a	  series	  of	  fluorescent	  model	  haptens,	  i.e.	  isothiocyanates	  and	  bromobimanes,	  
were	  applied	   to	   study	  different	  aspects	   in	   contact	  allergy.	  These	  haptens	  are	  discussed	   in	  
the	  following	  two	  sections.	  	  
3.2.1 Isothiocyanates	  
Isothiocyanates	  are	   strong	  electrophiles,	   and	  are	  potential	   sensitizers	  under	   the	  condition	  
that	  they	  penetrate	  the	  skin	  barrier.	  Indeed,	  several	  cases	  of	  ACD	  caused	  by	  isothiocyanates	  
have	  been	  reported.	  Specifically	  neoprene	  materials	  and	  adhesive	  tapes	  have	  been	  shown	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to	   be	   sources	   of	   sensitizing	   isothiocyanates,	   e.g.	   phenyl	   isothiocyanate	   is	   released	   from	  
rubber	  materials,	  as	  a	  degradation	  product	  from	  thioureas	  [56-­‐58].	  	  
Isothiocyanates	   are	   expected	   to	   form	   hapten	   protein	   complexes	   via	   conjugation	   to	   e.g.	  
lysine	  and	  cysteine	  amino	  acids	  or	  N-­‐terminus	  of	  proteins	  and	  peptides.	  However,	  only	  the	  
reaction	  with	  amines	  generates	  stable	  products.	  The	  reaction	  with	  cysteine	  is	  reversible	  and	  
thiol	   adducts	   can	   be	   converted	   into	   stable	   amine	   adducts	   under	   physiological	   conditions	  
[59]	   (Figure	   3.2).	   It	   has	   been	   shown	   that	   isothiocyanates	   reacts	   selectively	   with	   terminal	  
amines	  in	  proteins	  [60].	  
	  
Figure	   3.2.	   Reactivity	   of	   isothiocyanates	   with	   thiols	   and	   amines.	   Isothiocyanates	   reacts	   with	   thiols	   (e.g.	  
cysteine,	  a)	  leading	  to	  the	  formation	  of	  dithiocarbamates	  and	  with	  amines	  (e.g.	  lysine,	  b)	  generating	  thioureas.	  
	  	  
Fluorescent	   isothiocyanates	   are	   commonly	   used	   as	   labels	   for	   antibodies	   in	  
immunofluorescence	  techniques	  [60,	  61].	  Fluorescent	  isothiocyanates	  have	  also	  been	  used	  
as	  model	  haptens	   in	  mechanistic	   studies	  of	   contact	  hypersensitivity	   [62-­‐64].	   In	   this	   thesis,	  
fluorescein	  isothiocyanate	  (FITC)	  and	  rhodamine	  B	  isothiocyanate	  (RBITC)	  (Figure	  3.3)	  were	  
used	  as	  model	  haptens.	  FITC	  is	  a	  green	  fluorophore	  with	  excitation	  maximum	  near	  495	  nm	  
and	  an	  emission	  maximum	  at	  520	  nm.	  RBITC	  is	  a	  red	  fluorophore	  with	  excitation	  maximum	  
at	  543	  nm	  and	  an	  emission	  maximum	  near	  580	  nm	  [61].	  FITC	  was	  used	  initially	  but	  replaced	  
by	  RBITC,	  which	  has	  less	  overlap	  with	  the	  skin	  autofluorescence.	  
3.2.2 Bromobimanes	  
Bromobimanes	  (Figure	  3.3)	  is	  a	  group	  of	  halogenated	  thiol	  reactive	  caged	  fluorophores,	  i.e.	  
they	   are	  weakly	   fluorescent	   compounds	  which	   form	   highly	   fluorescent	   thioether	   adducts	  
with	  sulfhydryles	  via	  SN2	  displacement	  of	  one	  (mBBr)	  or	  two	  dBBr)	  bromines	  [65,	  66].	  The	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fluorescent	  bimane-­‐derivatives,	  formed	  upon	  alkylation	  with	  e.g.	  proteins	  or	  peptides,	  have	  
a	   excitation	   maximum	   around	   390	   nm	   and	   an	   emission	   maximum	   around	   480	   nm	   [67].	  
Bromobimanes	  have	  been	  used	  as	  labelling	  reagents	  for	  identification	  and	  quantification	  of	  
peptides	   and	   proteins	   in	   cells	   using	   various	   techniques,	   e.g.	   gel	   electrophoresis,	   liquid	  
chromatography,	  flow	  cytometry	  and	  fluorescence	  microscopy	  [68-­‐78].	  	  
In	  this	  thesis,	  the	  bromobimanes	  mBBr	  and	  dBBr	  were	  used	  as	  model	  sensitizers	  to	  identify	  
hapten	  targets	   in	  skin,	   i.e	  hapten	  protein	  complexes	  were	  visualized	  following	  uncaging	  of	  
the	  bromobimanes	  via	  conjugation	  to	  cutaneous	  proteins	  or	  peptides.	  
	  
	  
Figure	   3.3.	   Molecular	   structures	   of	   the	   model	   haptens	   fluorescein	   isothiocyanate	   (FITC),	   rhodamine	   B	  
isothiocyanate	   (RBITC),	  monobromobimane	   (mBBr)	   and	   dibromobimane	   (dBBr)	   and	   their	   non-­‐reactive,	   non-­‐
sensitizing	  structural	  analogues	  fluorescein,	  rhodamine	  B	  and	  syn-­‐(methyl,methyl)bimane,	  which	  were	  used	  as	  
control	  compounds.	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3.3 Predicting	  sensitization	  potency	  
When	   suspected,	   contact	   allergy	   can	   be	   diagnosed	   in	   a	   patch	   test	   performed	   by	  
dermatologists	   [51].	   Positive	   patch	   test	   reactions	   can	   have	   significant	   socio-­‐economic	  
consequences,	  both	   for	   the	   individual	   and	   society;	   e.g.	  numerous	   cases	  of	   contact	   allergy	  
are	  work-­‐related	   and	   often	   lead	   to	   long	   sick-­‐leaves	   and	   sometimes	   oblige	   the	   patient	   to	  
change	   profession.	   Preventive	   work,	   e.g.	   identification	   of	   haptens	   and	   removal	   and	  
replacement	  of	  allergenic	  compounds	  from	  the	  market,	  is	  therefore	  of	  great	  importance	  to	  
reduce	  the	  prevalence	  of	  contact	  allergy.	  Next	  to	  human	  volunteers	  [79-­‐81],	  animal	  models	  
e.g.	   the	  Guinea	   Pig	  Maximization	   Test	   [82,	   83],	   and	   the	  murine	   Local	   Lymph	  Node	   Assay	  
(LLNA)	   [84-­‐86]	   are	   probably	   the	   most	   reliable	   assays	   for	   predictive	   screening	   of	   contact	  
allergens.	  Presently	  it	  is	  the	  murine	  LLNA	  that	  is	  the	  most	  commonly	  adopted	  method.	  The	  
LLNA	  was	  applied	  to	  investigate	  the	  sensitization	  potency	  of	  the	  model	  haptens	  used	  in	  this	  
thesis.	  
3.3.1 The	  Local	  Lymph	  Node	  Assay	  
The	   murine	   LLNA	   (Figure	   3.4)	   is	   a	   validated	   standard	   test	   for	   predictive	   screening	   and	  
identification	  of	  sensitizing	  chemicals	  [87].	  In	  the	  LLNA,	  sensitization	  potency	  of	  a	  chemical	  
is	  evaluated	  by	  measuring	  a	  dose	  dependent	  proliferative	  response	   in	  the	  cells	  of	  the	  skin	  
draining	  cervical	  lymph	  node	  cell	  population.	  The	  LLNA	  assays	  presented	  in	  this	  thesis	  were	  
performed	  according	  to	  OECD	  recommendations.	  Briefly,	  18	  mice	  are	  divided	  in	  six	  groups	  
with	   three	   mice	   in	   each	   group.	   Each	   of	   five	   groups	   is	   then	   exposed	   to	   a	   single	   specific	  
concentration	  of	  the	  hapten	  in	  a	  test	  vehicle	  for	  3	  consecutive	  days	  (day	  1-­‐3).	  Concurrently,	  
the	   6th	   group	   (the	   control	   group)	   is	   exposed	   to	   the	   vehicle	   without	   the	   hapten.	   The	  
formulations	  are	  applied	   topically	  on	  the	  dorsal	   side	  of	   the	  ears.	  Three	  days	  after	   the	   last	  
application	  (day	  6)	  mice	  are	  injected	  with	  3H-­‐methyl	  thymidine	  and	  are	  sacrificed.	  	  Cervical	  
lymph	  nodes	  are	  excised,	   single	   cell	   suspensions	  are	  prepared	  and	   further	   treated	  before	  
analysis	  by	  β-­‐scintillation	  counting	  (day	  7).	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  Figure	  3.4.	  The	  murine	  local	  lymph	  node	  assay	  (LLNA).	  Day	  1-­‐3:	  	  Mice	  are	  treated	  with	  test	  formulations	  once	  
a	   day.	   Day	   3-­‐6:	   Incubation.	   Day	   6:	   Mice	   are	   injected	   with	   3H-­‐methyl	   thymidine,	   cervical	   lymph	   nodes	   are	  
excised	  and	  single	  cell	  suspensions	  are	  prepared.	  Day	  7:	  Analysis	  of	  single	  cell	  suspensions	  by	  beta-­‐scintillation	  
counting	  and	  calculation	  of	  stimulation	  index	  and	  EC3	  value.	  
	  
The	   β-­‐scintillation	   counter	  measures	   the	   amount	   of	   3H-­‐methyl	   thymidine	   incorporated	   in	  
DNA	  of	  the	  lymph	  node	  cells	  from	  each	  treatment	  group,	  and	  is	  expressed	  as	  disintegrations	  
per	  minutes	  (dpm).	  A	  stimulation	  index	  (SI)	  is	  calculated	  according	  to	  Equation	  1,	  where	  n	  is	  
the	  number	  of	  lymph	  nodes	  in	  each	  group.	  	  
𝑆𝐼 =    𝑑𝑝𝑚 𝑛 !"#$%#&𝑑𝑝𝑚 𝑛 !"#$%"&                     Equation  1	  
	  
The	   sensitizing	   capacity	  of	   chemicals	   tested	   in	   the	   LLNA	   is	   classified	  based	  on	  EC3	  values.	  
The	  EC3	  value	   is	   the	   concentration	  at	  which	   the	   lymph	  node	  cell	  proliferative	   response	   is	  
increased	  by	  a	  factor	  of	  three	  compared	  to	  a	  vehicle	  exposed	  control	  group,	  i.e.	  a	  SI	  equal	  to	  
3.	   A	   hapten	   can	   be	   classified	   as	   extreme	   (EC3	   <	   0.1%,	   w/v),	   strong	   (EC3	   <	   1	   %,	   w/v),	  
moderate	  (EC3	  <10	  %,	  w/v)	  or	  weak	  sensitizers	  (EC3	  <	  100%,	  w/v)	  according	  to	  a	  generally	  
adopted	  classification	  system	  [88].	  	  
The	  LLNA	  was	  employed	  to	  determine	  the	  sensitizing	  capacity	  of	  the	  model	  haptens	  used	  in	  
Paper	  II,	  IV	  and	  V.	  A	  modified	  non-­‐pooled	  LLNA	  was	  used	  in	  Paper	  III	  to	  perform	  a	  statistical	  
analysis	  of	  the	  variation	  in	  the	  sensitization	  potency	  of	  a	  hapten	  when	  applied	  in	  different	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vehicles.	  The	  statistical	  LLNA	  experiments	  were	  performed	  as	  the	  standard	  assay	  described	  
above	  with	   the	   following	  exceptions:	  only	   three	  groups	   (one	  control	  and	  two	  test	  groups)	  
with	   up	   to	   nine	   mice	   per	   group	   were	   used,	   the	   two	   test	   groups	   received	   the	   same	  
concentration	  of	   the	  hapten	  but	   in	  different	  vehicles	  and	  excised	   lymph	  nodes	   from	  each	  
mouse	  were	  treated	  and	  analyzed	  separately.	  	  All	  animal	  assays	  included	  in	  this	  thesis	  were	  
approved	  by	  the	  local	  ethics	  committee.	  	  	  	  	  	  	  
3.3.2 Alternative	  non-­‐animal	  based	  assays	  
In	   the	   past	   guinea	   pigs	   were	   frequently	   used	   for	   the	   identification	   of	   contact	   allergens.	  
Recently,	   guinea	   pig	   based	   assays	   became	   more	   or	   less	   replaced	   by	   the	   murine	   LLNA,	  
described	  above.	  Due	  to	  public	  concerns	  the	  use	  of	  animal	  based	  toxicity	  assays,	  e.g.	  in	  the	  
screening	   of	   products	   for	   identification	   of	   skin	   sensitizers,	   is	   now	   restricted	   by	   new	  
legislations	  within	  the	  European	  Union.	  An	  ban	  on	  animal	  testing	  of	  cosmetic	  products	  was	  
implemented	   in	   2009	   and	   there	   is	   a	   pending	   marketing	   ban	   on	   animal	   tested	   cosmetic	  
products,	   starting	   from	   2013	   according	   to	   the	   seventh	   amending	   directive	   [89]	   to	   the	  
European	   cosmetic	   directive	   [90].	   Thus,	   there	   is	   an	   urgent	   need	   for	   the	   development	   of	  
robust	   alternative	   methods,	   i.e.	   in	   vitro,	   in	   chemico	   or	   in	   silico	   models	   for	   predictive	  
screening.	  
Although,	  in	  vitro	  methods	  have	  been	  shown	  to	  be	  relatively	  successful	  in	  some	  cases,	  e.g.	  
to	   predict	   local	   toxicity,	   predicting	   the	   sensitization	   potency	   of	   chemicals	   remains	  
complicated.	  This	   is	  due	  to	  the	  many	  mechanisms	  involved	  and	  their	  complexity.	  Although	  
much	  effort	  has	  been	  made,	  a	  considerable	  amount	  of	  work	  is	  still	  a	  head	  before	  acceptable	  
alternative	   methods	   can	   be	   adopted,	   which	   could	   replace	   the	   murine	   LLNA.	   Example	   of	  
parameters	   which	   may	   influence	   on	   the	   sensitization	   potency	   of	   a	   hapten	   and	   must	   be	  
considered	  in	  the	  design	  of	  an	  in	  vitro	  test	  are	  autoxidation,	  skin	  penetration,	  bioavailability,	  
biotransformations,	  hapten-­‐protein	  reactivity	  and	  epitope	  recognition	  by	  T-­‐cells.	  A	  thorough	  
understanding	   of	   these	   processes	   and	   their	   influence	   on	   the	   sensitization	   potency	   of	  
haptens	  are	  important	  when	  designing	  alternative	  screening	  methods.	  
As	   it	   is	   difficult	   to	   include	   all	   the	   above-­‐mentioned	   parameters	   in	   a	   single	   assay	   it	   is	  
generally	  assumed	  that	  a	  toolbox	  of	  alternative	  methods	  will	  have	  to	  be	  used	  to	  replace	  e.g.	  
the	  murine	  LLNA.	  Until	  now,	  numerous	  different	  approaches	  have	  been	  investigated,	  e.g.	  in	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vitro	   cell	   based	   assays	   [91,	   92],	   in	   chemico	   peptide	   reactivity	   assays	   [93,	   94]	   and	   in	   silico	  
expert	   systems	   [95,	  96].	  A	  peptide	   reactivity	   assay	  and	   two	   the	   cell	   based	  assays,	   i.e.	   the	  
Myeloid	  U937	  skin	  sensitization	  test	  and	  the	  human	  cell	  line	  activation	  test	  are	  presently	  up	  
for	  pre-­‐validation	  by	   the	   European	  Centre	   for	   the	  Validation	  of	  Alternative	  Methods	   [97].	  
However,	   it	  has	  been	  pointed	  out	  that	  the	  deadlines	   for	  replacement	  of	   the	  animal	  based	  
assays	  with	  alternative	  methods	  are	  unrealistic,	  especially	  in	  quantitative	  risk	  assessment	  of	  
contact	  allergens	  [98].	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4 Cutaneous	  absorption	  	  
	  
Successful	  and	  safe	  delivery	  of	  topical	  drugs	  and	  cosmetics	  relies	  on	  effective	  formulations,	  
which	  maximize	  drug	  concentrations	  in	  target	  tissue.	  	  Some	  compounds	  are	  intended	  to	  stay	  
on	   the	   skin	   surface	   (sunscreens	   and	   barrier	   creams)	   [99-­‐101]	   and	   some	   in	   the	   stratum	  
corneum	  (moisturizers).	  Other	  should	  reach	  the	  viable	  epidermis	  of	  dermis	  (local	  analgesics,	  
antifungal	   agents	   and	   drugs	   used	   in	   photodynamic	   therapy)	   [102-­‐104],	   be	   taken	   up	  
systemically	   (nitroglycerine,	   and	   nicotine)	   [105]	   or	   are	   specifically	   targeting	   the	   PSUs	  
(retinoids)	  [106].	  	  Target	  specific	  delivery	  is	  not	  always	  an	  easy	  task,	  due	  to	  the	  complexity	  
of	  the	  skin	  and	  the	  skin	  barrier.	  Several	  different	  parameters	  will	  have	  to	  be	  considered	  and	  
optimized	   to	   achieve	  maximum	   effect	   of	   the	   active	   components	   while	   reducing	   negative	  
side	  effects	   in	  non-­‐target	  tissue.	  Cutaneous	  absorption	   is	  also	  highly	  relevant	  factor	   in	  risk	  
assessment,	  e.g.	   in	  the	   identification	  of	  skin	  sensitizers,	  as	  the	  sensitization	  potency	  partly	  
depends	   on	   the	   bioavailability	   of	   the	   hapten.	   This	   chapter	   will	   comprise	   an	   overview	   of	  
some	   of	   the	   processes	   related	   to	   uptake	   of	   xenobiotics	   by	   the	   skin	   (with	   respect	   to	   the	  
physical	  barrier)	  and	  factors	  affecting	  the	  uptake.	  It	  will	  also	  give	  an	  introduction	  the	  topical	  
delivery	  systems	  used	  in	  the	  studies	  presented	  in	  Paper	  I	  and	  III.	  For	  clarification,	  cutaneous	  
absorption	  will	  refer	  to	  the	  penetration	  of	  a	  topically	  applied	  compound	  into	  a	  specific	  layer	  
of	  the	  skin	  and	  percutaneous	  absorption	  refers	  to	  the	  uptake	  by	  the	  skin	  and	  the	  resorption	  
by	   the	   circulatory	   system,	   i.e.	   the	   lymph	   and	   the	   blood,	   in	   the	   dermis.	   Also,	   in	   the	  
discussion,	   the	   definition	   topical	   application	   or	   delivery	   will	   here	   only	   refer	   to	   external	  
epicutaneous	  administration.	  
4.1 Skin	  penetration	  pathways	  	  
The	  efficiency	  of	  a	  topical	  drug	  or	  the	  sensitizing	  potency	  of	  a	  hapten	  depends	  on	  the	  ability	  
of	  the	  compound	  to	  cross	  the	  stratum	  corneum	  and	  enter	  the	  viable	  compartments	  of	  the	  
skin	   and	   the	   circulation.	   The	   uptake	   over	   the	   stratum	   corneum	   can	   proceed	   via	   three	  
general	  pathways	  (Figure	  4.1),	  i.e.	  the	  intracellular	  route	  over	  the	  corneocytes,	  the	  tortuous	  
extracellular	   pathway	   via	   the	   lipid	   matrix,	   and	   the	   shunt	   pathway	   through	   the	   skin	  
appendages	  (PSU	  and	  sweat	  glands)	  [107].	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Figure	   4.1.	   Potential	   penetration	  pathways	   through	   the	   stratum	  corneum.	   Topically	   applied	   compounds	   can	  
enter	  the	  skin	  via	  shunts	  (e.g.	  the	  pilsosebaceous	  units	  and	  sweat	  glands),	  via	  the	  transcellular	  route	  over	  the	  
corneocytes	  or	  via	  the	  tortuous	  extracellular	  pathway	  in	  the	  lipid	  matrix	  (a).	  A	  three-­‐dimensional	  illustration	  of	  
the	  lipid	  matrix,	  composed	  of	  bilayers	  of	  polar	  lipids,	  i.e.	  ceramides,	  fatty	  acids	  and	  cholesterol	  (b).	  
Of	   these,	   the	   extracellular	   pathway	   via	   the	   lipid	  matrix	   is	   generally	   regarded	   as	   the	  most	  
important.	   Intracellular	   transport	   is	   limited	   due	   to	   the	   physical	   strength	   of	   the	   cornified	  
envelope	   and	   the	   dense	   keratinization	   of	   the	   corneocytes.	   Shunts	   may	   offer	   a	   relatively	  
rapid	  uptake	  through	  the	  stratum	  corneum	  and	  into	  the	  deeper	  skin	  layers;	  however	  these	  
are	   generally	   considered	   to	   play	  minor	   role	   in	   the	   total	   flux	   due	   to	   the	   relatively	   limited	  
surface	   area	   of	   the	   appendages,	   <1%	   of	   the	   skin	   surface	   [108,	   109].	   However,	   the	  
significance	   of	   shunt	   diffusion	   is	   debated.	   It	   has	   been	   suggested	   that	   transport	   via	   the	  
shunts	  could	  predominate	   in	  some	  specific	  cases,	  e.g.	   in	  the	  cutaneous	  absorption	  of	  very	  
polar	   compounds,	   compounds	   with	   relatively	   high	   molecular	   weight	   or	   larger	   particles	  
[109].	   Ultimately	   it	   is	   the	   physiological	   state	   of	   the	   skin	   barrier,	   chemical	   and	   physical	  
properties	  of	  the	  applied	  compound	  and	  the	  formulation	   in	  which	   it	   is	  applied	  on	  the	  skin	  
that	   determine	   the	   penetration	   pathways	   through	   the	   stratum	   corneum	   as	   well	   as	   the	  
amount	  the	  applied	  dose	  absorbed.	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4.2 Factors	  affecting	  the	  absorption	  of	  topically	  applied	  compounds	  
The	  cutaneous	  and	  percutaneous	  absorption	  of	  a	   topically	  applied	  compound	  depends	  on	  
several	  different,	   chemical	   (compound	  specific)	  and	  physiological	   (skin	  dependent)	   factors	  
(Table	   4.1).	   These	   factors	   may	   also	   indirectly	   affect	   the	   potency	   of	   a	   skin	   sensitizer.	  
Molecular	   weight	   and	   logP	   are	   important	  molecular	   properties	   regulating	   cutaneous	   and	  
percutaneous	  absorption.	  A	  low	  molecular	  weight	  and	  a	  logP	  around	  2	  is	  often	  regarded	  as	  
optimal	  for	  effective	  transdermal	  delivery	  [110].	  Compounds	  with	  a	  molecular	  weight	  larger	  
than	  1000	  Da	  are	  not	  assumed	  to	  penetrate	  healthy	  skin	  [111].	  Molecular	  weight,	  logP	  can	  
be	  used	  as	  predictors	   in	   in	   silico	   calculations	  of	   skin	  permeability	   coefficients	   (KP)	   in	   silico	  
[112,	  113].	  	  
Another	   important	  chemical	  parameter	   is	  binding.	  Conjugation	  to	  proteins	   in	  epidermis	  or	  
dermis	  may	  reduce	  the	  cutaneous	  absorption	  or	  lead	  to	  an	  accumulation	  of	  the	  compound	  
in	  a	  specific	  skin	  layer	  [114].	  This	  is	  a	  parameter,	  which	  has	  shown	  to	  be	  specifically	  relevant	  
when	   investigating	   the	   cutaneous	   absorption	   of	   haptens,	   as	  will	   be	   demonstrated	   in	   this	  
thesis.	   Examples	   of	   other	   chemically	   related	   factors	   are	   concentration,	   dose,	   hydrogen	  
donor	   and	   acceptor	   strength,	   pKa	   and	   vapour	   pressure.	   Physiological	   factors	   are	   also	  
important	  to	  consider.	  For	  example,	   local	  variations	  in	  e.g.	  stratum	  corneum	  thickness	  and	  
hair	   follicle	   density	   may	   influence	   the	   degree	   of	   absorption.	   Skin	   diseases	   or	   physical	  
damage	  to	  the	  skin	  barrier	  can	  also	  affect	  the	  uptake[114].	  	  
	  
Table	  4.1	  A	  summary	  of	  chemical,	  environmental	  and	  physiological	  factors	  affecting	  the	  
cutaneous	  absorption	  of	  xenobiotics.	  Adopted	  fom	  [114].	  
Chemical	  factors	   	   Environmental	  factors	   	   Physiological	  factors	  
Charge	   	   Concentration	   	   Age	  
Chemical	  reactivity	   	   Contact	  area	   	   Blood	  flow	  
H-­‐bond	  donor/acceptor	   	   Contact	  time	   	   Disease	  or	  damage	  
logP	   	   Dose	   	   Gender	  
Melting	  point	   	   Formulation/Vehicle	   	   Hair	  follicle	  density	  
MW	   	   Occlusion	   	   Metabolism	  
pKa	   	   pH	   	   Species	  
Vapor	  pressure	   	   Temperature	   	   Skin	  thickness	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4.3 Fick’s	  law	  of	  diffusion	  
Percutaneous	   absorption	   can	  be	   regarded	   as	  multi-­‐lamellar	  membrane	   transport	   process,	  
including	   a	   multiple	   partitioning	   and	   diffusion	   coefficients	   in	   the	   different	   skin	   layers,	  
controlling	  the	  overall	   flux.	  Stratum	  corneum	  diffusion	  coefficient	   is	  commonly	  considered	  
to	  be	  the	  rate-­‐limiting	  step	  in	  the	  cutaneous	  absorption	  of	  xenobiotics	  [115].	  One	  exception	  
could	  be	  very	  lipophilic	  compounds	  were	  the	  partitioning	  from	  the	  stratum	  corneum	  to	  the	  
more	   hydrated	   environment	   in	   the	   viable	   epidermis	   could	   be	   the	   rate	   limiting	   step.	   In	   a	  
general	  approximation,	  stratum	  corneum	   is	   regarded	  as	  an	   inert	  homogenous	  membrane,	  
and	  percutaneous	  absorption	  is	  treated	  as	  a	  classical	  membrane	  transport	  phenomena,	  i.e.	  
a	   passive	   diffusion	   driven	   by	   a	   concentration	   gradient	   [116].	   Consequently,	   cutaneous	  
absorption	  can	  be	  analyzed	  according	  to	  the	  general	  Law	  of	  mass	  transfer	  and	  Fick’s	  Laws	  of	  
diffusion.	  Fick’s	  first	  law	  of	  diffusion	  (Equation	  2)	  states	  that	  the	  flux	  (J),	  i.e.	  the	  number	  of	  
absorbed	   molecules	   per	   unit	   area	   and	   unit	   time	   is	   proportional	   to	   the	   concentration	  
gradient	  (ΔC)	  over	  the	  skin.	  
	  
𝐽 =   𝐾!Δ𝐶 = 𝐾𝐷Δ𝐶𝑙                     Equation  2	  
	  
The	   proportionality	   constant	   (KP),	   called	   the	   permeability	   coefficient,	   is	   a	  measure	   of	   the	  
diffusion	   rate	   (cm/h)	   of	   a	   topically	   applied	   compound	   through	   the	   skin.	   The	   permeability	  
coefficient	   is	   the	  product	  of	   the	  partition	  coefficient	   (K)	  between	   the	  vehicle	  and	  stratum	  
corneum	  and	  the	  diffusion	  coefficient	   (D)	   in	   the	  stratum	  corneum	  divided	  by	   the	  diffusion	  
path-­‐length.	   However,	   the	   skin	   is	   a	   complex,	   heterogeneous,	   biologically	   active	   structure	  
and	  several	  deviations	  from	  this	  approximation	  are	  likely	  to	  be	  observed.	  	  
4.4 Topical	  delivery	  systems	  
Effective,	  target	  specific	  uptake	  of	  drugs	  is	  one	  of	  the	  big	  challenges	  in	  the	  pharmaceutical	  
industry.	   While	   oral	   administration	   is	   by	   far	   the	   most	   commonly	   used	   method	   it	   is	   not	  
always	  the	  most	  appropriate.	  For	  example,	  oral	  administration	  is	  not	  suitable	  if	  the	  drug	  is	  
sensitive	   to	   metabolic	   transformations	   in	   the	   liver	   or	   in	   the	   gastro-­‐intestinal	   tract.	   	   Oral	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administration	  is	  neither	  the	  best	  choice	  when	  a	  prolonged	  continuous	  release	  is	  desirable	  
[117].	   In	   some	  cases	  epicutaneous	  administration	  might	  be	  good	  alternative,	   especially	   in	  
local	  therapy	  of	  skin	  related	  diseases.	  However,	  epicutaneous	  delivery	  is	  often	  hampered	  by	  
the	   low	   permeability	   of	   the	   skin	   barrier.	   	   Thus,	   much	   effort	   is	   being	   made	   in	   the	  
development	  of	  efficient	  topical	  formulations.	  	  	  
Epicutaneous	  formulations	  must	  be	  adapted	  depending	  on	  the	  target	  tissue,	  e.g.	  maximizing	  
the	   percutaneous	   absorption	   of	   systemically	   active	   drugs	   or	   target	   specific	   skin	  
compartments	  in	  the	  treatment	  of	  skin	  related	  diseases.	  Similarly,	  formulations	  of	  cosmetic	  
product	  must	  be	  optimized	  in	  order	  to	  improve	  their	  efficiency	  and	  to	  minimize	  the	  risk	  of	  
unwanted	  side	  effects.	  Often	  cosmetic	  products,	  compared	  to	  drugs,	  are	  intended	  to	  act	  on	  
the	   surface	   of	   the	   skin,	   alternatively	   in	   the	   uppermost	   layers	   of	   the	   stratum	   corneum.	  
Penetration	   into	   the	   viable	   compartments	   of	   the	   skin	   or	   systemic	   uptake	   is	   generally	  
undesirable.	   Development	   of	   formulations	   reducing	   the	   uptake	   while	   maintaining	   the	  
specific	   cosmetic	   effect	   could	   lead	   to	   safer	   consumer	   products.	   Interestingly,	   although	  
having	  opposite	  aims,	  with	  the	  pharmaceutical	  industry	  wanting	  to	  improve	  the	  absorption	  
whereas	   cosmetic	   industry	  wants	   to	   reduce	   the	   absorption,	   pharmaceutical	   and	   cosmetic	  
cutaneous	   formulations	   are	   often	   based	   on	   same	   formulation	   strategies	   using	   emulsion	  
based	  delivery	  systems	  [118].	  
4.4.1 Cutaneous	  penetration	  enhancers	  
Many	  different	  penetration	  enhancing	  formulations	  and	  strategies	  has	  been	  investigated	  in	  
order	  to	  improve	  the	  absorption	  of	  topically	  applied	  drugs.	  Chemical	  penetration	  enhancers	  
are	   pharmacologically	   inactive	   compounds,	   applied	   in	   order	   to	   increase	   uptake	   of	   drugs	  
from	  a	  topical	  formulation	  [119].	  Some	  chemical	  enhancers	  are	  thought	  alter	  drug	  solubility	  
in	  either	  the	  formulation	  or	  in	  the	  stratum	  corneum	  changing	  the	  stratum	  corneum-­‐vehicle	  
partitioning	  coefficient.	  Other	  enhancers	  are	  thought	  influence	  the	  drug	  diffusion	  in	  stratum	  
corneum,	  e.g.	  by	  disruption	  and	  fluidization	  of	  the	  ordered	  lamellar	  lipid	  bilayer	  structure	  or	  
by	  stratum	  corneum-­‐lipid	  extraction	  [109,	  120].	  The	  exact	  mechanism	  of	  many	  penetration	  
enhancers	   remains	   speculative.	   Physical	   enhancers,	   e.g.	   dermal	   patches	   with	   occlusive	  
effect	   [105,	   121,	   122],	   iontophoresis,	   i.e.	   electric	   potential	   driven	   transport	   of	   charged	  
molecules	  over	  stratum	  corneum	  [123,	  124]	  and	  physical	  disruption	  of	  the	  stratum	  corneum,	  
e.g.	  using	  micro-­‐needles	  	  [125],	  can	  be	  used	  to	  improve	  transdermal	  delivery	  of	  drugs.	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4.4.2 Lipid	  based	  formulations	  
When	   amphiphilic	   molecules	   are	   suspended	   in	   aqueous	   solutions,	   they	   self-­‐assemble	   in	  
order	  to	  minimize	  the	  contact	  between	  hydrophobic	  parts	  of	  the	  molecules	  and	  the	  solvent	  
system.	  The	  phase	  separation	  leads	  to	  the	  formation	  of	  various	  structures,	  e.g.	  spherical	  or	  
cylindrical	  micelles,	   lamellar	  phases,	  bicontinuous	  structures	  or	  vesicles.	  The	  structure	  that	  
is	  formed	  depends	  on	  several	  different	  factors,	  e.g.	  the	  molecular	  structure	  of	  the	  surfactant	  
and	   its	   critical	   packing	   parameter,	   the	   solvent	   system,	   the	   temperature	   and	   the	  
concentration[126].	  
The	   simplest	   forms	   of	   self-­‐assembly	   are	   spherical	  micelles,	   generally	   formed	   in	   relatively	  
dilute	   concentrations	   of	   surfactant	   in	   aqueous	   solutions	   (at	   the	   critical	   micelle	  
concentration,	  CMC)	   [126].	  At	   increasing	   concentration	  micelles	   can	  grow	   into	   thread	   like	  
cylindrical	   micelles	   which	   eventually	   overlap	   and	   form	   a	   liquid	   crystalline	   bicontinuous	  
phase,	  composed	  of	   two	  continuous	  hydrophilic	   solvent	  phases	  and	  a	   lipophilic	   surfactant	  
phase	  [126].	  Two	  different	  lipid-­‐based	  delivery	  systems	  were	  studied	  in	  the	  work	  connected	  
to	  this	  thesis.	  The	  potential	  of	  bicontinuous	  cubic	  phases	   in	  topical	  delivery	  of	  drugs	  were	  
investigated	  in	  Paper	  I,	  and	  effect	  of	  lipid	  vesicles	  on	  the	  sensitization	  potency	  of	  a	  hapten	  
was	  investigated	  in	  Paper	  III	  and	  these	  are	  discussed	  in	  more	  detail	  below.	  	  
4.4.3 Bicontinuous	  cubic	  phases	  
Bicontinuous	   cubic	   phases	   (Figure	   4.2)	   have	   been	   shown	   to	   be	   promising	   drug	   delivery	  
system	  [127].	  One	  of	   their	  main	  advantages	   is	   the	  ability	   to	  dissolve	  both	  hydrophilic	  and	  
lipophilic	  compounds.	  This	  is	  due	  to	  the	  bipolar	  structure	  of	  the	  system	  [118].	  Bicontinuous	  
cubic	   phases	   have	   also	   proven	   to	   be	   effective	   formulations	   in	   epicutaneous	   delivery	   of	  
drugs.	  Monoolein	   (MO)	   and	   phytantriol	   (PT)	   (Figure	   4.2)	   are	   polar	   lipids	   forming	   reverse	  
bicontinuous	   cubic	   phase	   in	   water.	   The	   MO	   and	   PT	   based	   cubic	   phases	   consists	   of	   a	  
continuous	  lipid	  bilayer	  (3-­‐4	  nm)	  and	  two	  water	  channels	  (5-­‐6nm)	  [118].	  Bender	  el	  al.	  have	  
previously	   shown	   that	   topical	   delivery	   of	   aminolaevulinic	   acids,	   used	   in	   photodynamic	  
therapy,	  can	  be	   improved	  when	  applied	   in	  MO	  and	  PT	  based	  cubic	  phases	  compared	  to	  a	  
commercial	   ointment	   composed	   of	   a	   micro-­‐emulsion	   in	   mice	   [128].	   However,	   the	  
mechanism	  was	  unknown	  and	  was	  therefore	  further	  investigated	  in	  Paper	  I.	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4.4.4 Lipid	  vesicles	  
Lipid	   vesicles	   are	   colloidal	   particles	   formed	  by	   amphiphatic	  molecules,	   e.g.	   phospholipids,	  
suspended	   in	   aqueous	   solutions.	   The	   lipids	   are	   organized	   in	   bilayers,	   which	   close	   on	  
themselves	   forming	   unilamellar	   or	   multilamellar	   (depending	   on	   the	   formulation	   and	  
preparation),	   spherical	   shaped	   structures	  with	  aqueous	   cores	   (Figure	  4.2).	   The	   size	  of	   the	  
vesicles	  may	  range	  from	  approximately	  20-­‐25	  nm	  up	  to	  a	  few	  microns	  [129].	  The	  first	  Paper	  
describing	  the	  formation	  of	  phospholipid	  vesicles,	  liposomes,	  were	  published	  in	  1965	  [130].	  
Investigations	  of	  the	  use	  of	  liposomes	  in	  topical	  formulation	  started	  in	  the	  beginning	  of	  1980	  
[131].	   Since	   then	   there	   has	   been	   an	   increasing	   interest	   for	   lipid	   vesicles	   in	   skin	   related	  
products,	  from	  both	  the	  pharmaceutical	  and	  the	  cosmetic	  industries.	  Like	  the	  cubic	  phase,	  
lipid	  vesicles	  can	  dissolve	  high	  concentration	  of	  both	  lipophilic	  and	  hydrophilic	  compounds.	  
It	  has	  also	  been	  shown	  that	  lipid	  vesicles	  can	  improve	  local	  delivery	  and	  sustained	  release	  of	  
topical	   drugs	   [131-­‐137].	   Furthermore,	   vesicles	   made	   of	   phospholipids	   have	   high	  
biocompatibility	  and	  are	  therefore	  considered	  relatively	  safe	  to	  use	  [138].	  	  
As	   lipid	  vesicles	  are	   included	   in	  many	   formulations,	  we	  wanted	   to	   study	  how	  these	  affect	  
the	  sensitization	  potency	  of	  haptens.	  The	   lipid	  vesicles	  used	   in	  Paper	   III	  were	  prepared	  by	  
suspending	   1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐phosphocholine	   (POPC,	   Figure	   4.2)	   in	   a	   40	  %	  
ethanol	   in	  water	   solution.	   Lipid	  vesicles	  prepared	  using	  ethanol	   in	   the	   aqueous	  phase	  are	  
commonly	  referred	  to	  as	  ethosomes.	  This	  type	  of	  vesicles	  were	  first	  introduced	  by	  Touitou	  
et	  al	   [139].	  Nano-­‐scale	  vesicles	  (<	  100	  nm)	  were	  prepared	  using	  extrusion	  technique	  [140]	  
and	  micro-­‐scale	  vesicles	  were	  prepared	  by	  the	  thin	  film	  hydration	  method	  [141].	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Figure	   4.2.	   Molecular	   structures	   of	   Monoolein	   (MO),	   phytantriol	   (PT),	   1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐
phosphocholine	   (POPC,	  a).	  An	  extruder	  used	   for	   the	  preparation	  of	   nano-­‐scale	   vesicle	   systems	   (b).	  A	   three-­‐
dimensional	  illustration	  of	  a	  lipid	  vesicle	  (c).	  	  A	  three-­‐dimensional	  illustration	  of	  a	  bicontinuous	  cubic	  phase	  (d).	  
	  
4.5 Methods	  to	  study	  cutaneous	  and	  percutaneous	  absorption	  of	  
topically	  applied	  compounds	  
There	  is	  a	  rather	  extensive	  collection	  of	  tools	  and	  techniques,	  which	  can	  be	  used	  to	  analyze	  
the	   cutaneous	   and	   percutaneous	   absorption	   of	   topically	   applied	   compounds.	   The	   choice	  
should	   ideally	  be	  made	  based	  on	  the	  aim	  of	  the	  study,	  and	  a	  combination	  of	  two	  or	  more	  
complementing	   techniques	   will	   generally	   give	   the	   best	   picture	   of	   the	   reality.	   However,	  
compromises	   might	   have	   to	   be	   done	   depending	   on	   e.g.	   the	   available	   equipment	   and	  
materials,	  ethical	  considerations	  and	  technical	  expertise.	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In	  clinical	  studies,	  tape	  stripping	  and	  dermal	  micro-­‐dialysis	  are	  commonly	  used	  techniques	  
to	  measure	  local	  concentrations	  of	  topically	  applied	  drugs	  [142,	  143]	  while	  blood	  and	  urine	  
analyses	  are	  used	  to	  analyze	  the	  systemic	  absorption	  [144,	  145].	  Pharmacodynamic	  activity	  
can	   also	   be	   used	   to	   assess	   the	   bioavailability	   of	   some	   drugs.	   However,	   it	   is	   not	   always	  
suitable	  or	  practically	  possible	  to	  perform	  analysis	  on	  patients.	  As	  an	  alternative,	  laboratory	  
animals	   can	   be	   used	   or	   measurements	   can	   be	   performed	   in	   vitro	   using	   excised	   or	  
reconstructed	   skin	   or	   synthetic	   membranes	   in	   diffusion	   cells.	   Another	   alternative	   is	  
calculation	  of	  permeability	  and	  diffusion	  constants	  in	  silico,	  based	  on	  the	  intrinsic	  molecular	  
properties	  of	  the	  investigated	  compound,	  e.g.	  molecular	  weight	  and	  logP	  [112,	  113].	  	  
Diffusion	  cells	  (Figure	  4.3)	  are	  one	  of	  the	  most	  frequently	  used	  in	  vitro	  methods	  to	  analyze	  
the	   cutaneous	   uptake	   of	   topically	   applied	   compounds	   [146].	   Briefly,	   a	   skin	   sample	   is	  
mounted	   between	   a	   donor	   and	   receiver	   compartment.	   The	   donor	   compartment	   is	   filled	  
with	  a	  receiver	  solution	  and	  the	  investigated	  formulation	  is	  applied	  on	  the	  skin	  in	  the	  donor	  
compartment.	   The	   receiver	   solution	   is	   sampled	   at	   specific	   time	   intervals	   (static	   diffusion	  
cells)	  or	  continuously	  (flow	  through	  diffusion	  cells)	  and	  the	  concentration	  of	  the	  compound	  
is	  analyzed	  using	  a	  suitable	  method	  depending	  on	  the	  compound	  investigated.	  The	  rate	  of	  
change	   in	   the	   concentration	   in	   the	   receiver	   solution	   can	  be	  used	   to	   calculate	   the	   flux	   (J),	  
diffusion	  constant	  (D)	  and	  the	  permeability	  constant	  (P)	  for	  the	  compound	  in	  the	  membrane	  
according	  to	  Fick’s	  first	  law	  (Equation	  3).	  Assuming	  infinite	  dose	  conditions	  and	  steady	  state	  
diffusion,	  ΔC	  can	  be	  substituted	  with	  the	  concentration	  in	  the	  vehicle,	  CV.	  
	  
Figure	  4.3.	  Tools	  for	  in	  vitro	  analysis	  of	  percutaneous	  absorption.	  A	  flow	  through	  diffusion	  cell	  (a)	  and	  a	  static	  
diffusion	  cell	  (b).	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Permeability	   coefficients	   derived	   from	   analysis	   using	   diffusion	   cells	   are	   often	   used	   as	   a	  
relative	  measurement	  of	  the	  bioavailability	  of	  topically	  applied	  compounds	  in	  drug	  delivery	  
and	   toxicological	   studies.	   Diiffusion	   cells	   measures	   only	   the	   amount	   of	   compound	   going	  
through	  the	  skin,	  an	  approximation	  of	  the	  systemic	  bioavailability.	   It	  does	  not	  provide	  any	  
information	   regarding	   local	   tissue	   concentrations.	   Calculated	   permeability	   coefficients	  
obtained	  by	  measuring	  the	  flux	  of	  two	  different	  compounds	  or	  a	  single	  compound	  from	  two	  
different	   formulations,	   do	   not	   necessarily	   reflect	   the	   relative	   drug	   concentrations	   in	   the	  
skin.	   Tape	   stripping	   and	   skin	   extraction	   can	   be	   used	   to	   obtain	   additional	   information	  
regarding	   local	   tissue	   concentrations,	   i.e.	   using	   the	   Saarbrücken	  penetration	  model	   [147].	  
Neither	  tape	  stripping	  nor	  skin	  extraction	  techniques	  have	  been	  used	  in	  this	  thesis	  and	  will	  
therefor	  not	  be	  discussed	  in	  more	  detail	  here.	  
Although	   the	   methods	   discussed	   in	   this	   chapter	   successfully	   predict	   the	   cutaneous	   or	  
percutaneous	   bioavailability	   of	   topically	   applied	   compounds,	   they	   have	   a	   common	  
limitation,	  i.e.	  they	  provide	  a	  relatively	  restricted	  insight	  into	  what	  is	  actually	  happening	  in	  
the	  skin.	  In	  addition,	  using	  tape	  stripping	  and	  skin	  extraction,	  the	  vertical	  resolution	  of	  the	  
cutaneous	   drug	   distribution	   is	   relatively	   poor	   and	   the	  methods	   do	   not	   take	   into	   account	  
variations	   in	  the	  horizontal	  distribution.	  Optical	   techniques,	  e.g.	   fluorescence	  and	  electron	  
microscopy,	   can	   therefor	   give	   a	  better	   picture	  of	   intracutaneous	  processes	   related	   to	   the	  
uptake	  of	  xenobiotics	  as	  will	  be	  discussed	  in	  the	  next	  chapter.	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5 Laser	  Scanning	  Microscopy	  	  
	  
Electron	  microscopy	   provides	   outstanding	   resolution,	   and	   can	   be	   used	   to	   study	   e.g.	   skin	  
morphology	   and	   vehicle-­‐induced	   ultra-­‐structural	   modification	   of	   the	   skin	   barrier	   [6,	   148-­‐
150].	  However	  it	  is	  limited	  to	  analysis	  of	  fixed	  sectioned	  samples.	  Fluorescence	  microscopy,	  
e.g.	   laser	   scanning	   confocal	   microscopy	   and	   non-­‐linear	   two-­‐photon	   laser	   scanning	  
microscopy	   (TPM),	   has	   a	   lower	   resolution,	   but	   afford	   direct	   3D	   visualization	   of	   processes	  
and	  structures	   in	   intact	  unfixed	  tissue,	   in	  or	  close	  to	   in	  vivo	   conditions.	  Both	  confocal	  and	  
TPM	  can	  be	  used	   for	   tissue	   imaging;	   however,	   TPM	   is	   in	  many	   respects	   a	  more	  powerful	  
technique	  for	  for	  non-­‐invasive	  visualization.	  In	  this	  thesis	  both	  techniques	  has	  been	  applied	  
and	   will	   thus	   be	   reviewed	   below.	   As	   TPM	   has	   been	   in	   focus	   of	   the	   present	   work,	   more	  
emphasis	  will	  be	  given	  to	  this	  technique.	  
	  
5.1 Laser	  scanning	  confocal	  microscopy	  
Confocal	  microscopy	  is	  a	  well-­‐established	  imaging	  technique,	  and	  an	  important	  tool	   in	  e.g.	  
studies	   of	   biological	   systems.	   Detailed	   information	   regarding	   the	   basics	   of	   laser	   scanning	  
confocal	   microscopy	   can	   be	   found	   elsewhere	   [151].	   Briefly,	   in	   fluorescence	   confocal	  
microscopy	  signal	   is	  generated	  via	  single-­‐photon	  excitation	  of	   fluorophores.	  The	  sample	   is	  
irradiated	   with	   light	   having	   an	   energy	   corresponding	   to,	   or	   close	   to,	   the	   one-­‐photon	  
absorption	   maximum	   of	   the	   compound	   to	   be	   imaged.	   When	   irradiated	   molecules	   are	  
excited	   from	  a	   ground	  electronic	   state	   (S0)	   to	   an	   excited	   electronic	   state	   (S1).	   The	   energy	  
difference	  between	  S0	  and	  S1	  corresponds	  to	  the	  energy	  of	  the	  illumination	  light.	  The	  signal	  
is	  generated	  when	  the	  molecules	  return	  to	  their	  ground	  electronic	  state	  and	  emits	  a	  photon	  
(Figure	  5.1).	  
In	   a	   conventional	   fluorescence	   microscope	   the	   entire	   field	   of	   view	   of	   the	   sample	   is	  
illuminated	   and	   imaged	   simultaneously.	   This	   has	   some	   advantages,	   e.g.	   faster	   image	  
acquisition.	  An	  important	  drawback	  is	  a	  rather	  poor	  depth	  discrimination	  of	  the	  signal.	  In	  a	  
laser	   scanning	   confocal	   system	   depth	   discrimination	   is	   achieved	   by	   point	   scanning	   the	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illumination	  beam	  over	  the	  sample.	  The	  fluorescence	  signal	  from	  the	  focal	  volume	  returns	  
via	   the	   objective	   lens	   and	   the	   scanning	   system	   and	   is	   focused	   on	   a	   detector.	   A	   pinhole	  
placed	  in	  front	  of	  the	  detector	  function	  as	  a	  spatial	  filter,	  excluding	  out	  of	  focus	  light.	  	  	  
Optical	  sectioning	  is	  a	  non-­‐invasive	  technique	  to	  dissecting	  and	  visualizing	  the	  interior	  of	  e.g.	  
biological	  samples.	  Briefly,	  a	  z-­‐stack	  of	  images	  are	  collected	  by	  scanning	  the	  fluorescence	  in	  
the	  x,y-­‐plane	  at	  successive	  sample	  depths.	  The	  image	  stack	  can	  then	  be	  combined	  into	  a	  3D	  
(x,	  y,	  z)	  representation	  of	  the	  sample.	  In	  this	  work,	  a	  Zeiss	  510	  Meta	  and	  a	  LSM	  710	  system	  
has	  been	  used,	  and	  tissue	  preparation	  has	  involved	  cryosectioning	  and	  immunofluorescence	  
techniques.	  	  	  
5.2 Laser	  scanning	  two-­‐photon	  microscopy	  
TPM	   is	   fast	   growing	   technique	   within	   the	   field	   of	   biomedical	   imaging	   and	   it	   has	   been	  
adopted	  in	  a	  wide	  range	  of	  research	  areas.	  TPM	  is	  especially	  suitable	  for	  live	  cell	  and	  in	  vivo	  
imaging	   and	   has	   been	   used	   to	   visualize	   e.g.	   lymphocyte	  mobility	   [152]	   and	   dendritic	   cell	  
networks	  in	  intact	  lymph	  nodes	  [153],	  T-­‐cell	  priming	  by	  dendritic	  cells	  in	  lymph	  nodes	  [154],	  
blood	  flow	  dynamics	  deep	  into	  the	  brain	  of	  living	  rats	  [155]	  and	  the	  dynamics	  and	  functions	  
of	   Langerhans	   cells	   in	   lymph	   nodes	   [156].	   TPM	   has	   also	   been	   adopted	   to	   study	   skin	  
morphology	   and	   the	   interactions	   between	   the	   skin	   and	   topically	   applied	   compounds	   and	  
formulations,	  e.g.	  to	  investigate	  the	  effect	  of	  penetration	  enhancers	  in	  topical	  formulations	  
[157,	   158]	   the	   uptake	   of	   nano-­‐particle	   borne	   drugs	   [159]	   and	   the	   interaction	   of	   vesicle	  
formulation	  with	  human	  skin	  [149]	  .	  TPM	  has	  also	  been	  evaluated	  as	  a	  tool	  for	  non-­‐invasive	  
optical	   diagnostic	   of	   skin	   cancer	   [160].	   The	   construction	   of	   a	   two-­‐photon	   is	   similar	   to	   a	  
confocal	  microscope,	  i.e.	  it	  is	  a	  laser	  scanning	  system	  in	  which	  images	  are	  acquired	  by	  raster	  
scanning	  the	  sample.	  A	  major	  distinction	  between	  the	  two	  techniques	  is	  the	  generation	  of	  
signal,	  i.e.	  the	  excitation	  process.	  
5.2.1 Two-­‐photon	  excitation	  
As	   described	   above,	   in	   a	   confocal	   microscope	   fluorescence	   signal	   is	   generated	   via	   one	  
photon	  excitation,	   i.e.	  with	  light	  having	  an	  energy	  corresponding	  to	  the	  potential	  between	  
the	   electronic	   states	   S0	   and	   S1	   of	   the	   investigated	   compound.	   In	   TPM,	   the	   same	   signal	   is	  
induced	   via	   a	   two-­‐photon	   excitation	   process,	   i.e.	   transfer	   from	   S0	   to	   S1	   proceeds	   via	   a	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simultaneous	   (10-­‐16	   s)	   absorptions	   of	   two	   photons,	   each	   having	   approximately	   half	   the	  
energy	  of	  the	  potential	  between	  S0	  and	  S1	  	  (Figure	  5.1).	  	  
Two-­‐photon	  excitation	  was	   theoretically	  predicted	  by	  Maria	  Göppert-­‐Mayer	   in	  1931	   [161]	  
and	  practically	  demonstrated	  	  by	  Kaiser	  and	  Garret	  in	  1961	  [162].	  However,	  the	  technique	  
remained	  in	  the	  hands	  of	  the	  ‘spectroscopist’	  until	  1992	  when	  Denk	  and	  coworkers	  realized	  
the	   first	   imaging	   system	   based	   on	   two-­‐photon	   excitation	   by	   combining	   a	   laser	   scanning	  
systems	  and	  a	  high	  intensity	  pulsed	  infrared	  laser	  [163].	  
The	  probability	  of	  a	  two-­‐photon	  excitation	  depends	  on	  the	  intensity	  of	  the	  excitation	  light.	  
Under	  normal	  light	  conditions,	  it	  is	  unlikely	  that	  a	  molecule	  absorbs	  two	  photons	  within	  the	  
same	  quantum	  moment,	   e.g.	   the	   probability	   for	   a	   one-­‐	   and	   a	   two-­‐photon	   excitation	   of	   a	  
molecule	   of	   Rhodamine	   B	   in	   bright	   sunlight,	   is	   approximately	   once	   every	   second	  
respectively	   once	   every	   10	   million	   years	   [164].	   The	   output	   power	   from	   a	   conventional	  
continuous	  wave	  laser,	  used	  in	  a	  standard	  confocal	  imaging	  system,	  is	  around	  100	  000	  times	  
to	  low	  to	  generate	  measurable	  amounts	  of	  two-­‐photon	  induced	  fluorescence	  [164].	  
In	  TPM,	  the	  rate	  of	  the	  two-­‐photon	  excitation	  is	  increased	  to	  measurable	  levels,	  by	  focusing	  
a	  high	  intensity	  pulsed	  laser	  beam	  with	  a	  high	  numerical	  aperture	  objective.	  A	  pulsed	  laser	  
enables	  the	  use	  of	  a	  very	  high	  peak	  power	  while	  keeping	  the	  average	  power	  low	  enough	  not	  
to	  damage	  the	  sample.	  For	  example,	  a	  pulsed	  titanium:saphire	  laser	  is	  normally	  operated	  at	  
approximately	  80	  MHz	  with	  a	  pulse	  duration	  time	  of	  around	  100	  fs.	  Thus	  the	  laser	  is	  on	  only	  
approximately	  8	  μs	  per	  second	  keeping	  the	  average	  output	  from	  the	  laser	  on	  the	  same	  level	  
as	   a	   conventional	   continuous	  wave	   laser.	   As	   intensity	   depends	   on	   the	   surface	   (photon×s-­‐
1×cm-­‐2),	   focusing	   the	   laser	   beam	  with	   a	   high	   NA	   objective	   (~10-­‐9	   cm2)	   generates	   enough	  
photons	  in	  the	  focal	  volume	  [165].	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Figure	  5.1.	  Principles	  of	  optical	  sectioning	  in	  confocal	  and	  two-­‐photon	  microscopy.	  In	  confocal	  microscopy,	  the	  
fluorescence	   is	  generated	  using	  UV-­‐Vis	  excitation	   light.	  The	  signal	   is	   collected	  via	   the	  objective	   lens	  and	   the	  
scanning	  unit	  (not	  shown)	  and	  focused	  on	  a	  detector.	  A	  pinhole	  placed	  in	  front	  of	  the	  detector	  function	  as	  a	  
spatial	   filter,	   excluding	   out	   of	   focus	   light	   (a).	   In	   TPM,	   fluorescence	   is	   induced	   using	   near	   infrared	   light	   and	  
optical	   sectioning	   can	   be	   achieved	   without	   the	   pinhole	   due	   to	   the	   intrinsically	   confined	   excitation	   volume	  
(green	   dot,	   arrow,	   b).	   	   Jablonski	   diagram,	   showing	   the	   generation	   of	   fluorescence	   (F)	   via	   a	   single-­‐photon	  
excitation	  (1PE,	  c)	  and	  a	  two-­‐photon	  excitation	  (2PE,	  d).	  A	  single-­‐photon	  excitation	  of	  a	  fluorescent	  compound	  
leads	  to	  a	  Stokes	  shift	  and	  a	  fluorescent	  signal	  at	  a	  longer	  wavelength.	  In	  TPM	  the	  emitted	  light	  has	  a	  shorter	  
wavelength	  compared	  to	  the	  excitation	  wavelength	  (e).	  
	  
The	  probability	  of	  a	  two-­‐photon	  excitation	  can	  be	  calculated	  according	  to	  Equation	  3,	  where	  
δ2	  is	   the	  two-­‐photon	  cross	  section,	  Pave	   the	  time	  averaged	  power	  of	   the	  excitation	   light,	   fP	  
the	   frequency	   of	   the	   pulsed	   laser,	   τ	   the	   pulse	   duration	   time,	   NA	   the	   numerical	   aperture	  
objective	  and	  λ	  the	  wavelength	  of	  the	  excitation	  light	  [166].	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5.2.2 Optical	  sectioning	  
Compared	   to	   confocal	  microscopy,	   optical	   sectioning	   is	   improved	   in	   TPM	  due	   to	   superior	  
penetration	  of	  the	  near	  infrared	  illumination	  light,	  which	  is	  the	  so	  called	  ‘optical	  window’	  of	  
tissue	  [165,	  167].	  As	  the	  two-­‐photon	  excitation	  depends	  on	  the	  absorption	  of	  two	  photons	  
there	   is	   a	   quadratic,	   nonlinear,	   relationship	   between	   the	   fluorescence	   emission	   and	   the	  
intensity	   of	   the	   illumination	   light.	   Thus	   the	   rate	   of	   the	   two-­‐photon	   excitation	   decreases	  
rapidly	   outside	   the	   focal	   volume.	   This	  means	   that	   all	   signals	   come	   from	  molecules	   in	   the	  
focal	   volume	   and	   optical	   sectioning	  without	   using	   a	   pinhole	   is	   possible.	   Hence,	   all	   signal,	  
also	  scattered	  photons	  from	  the	  focal	  volume	  can	  be	  detected,	  improving	  the	  sensitivity	  and	  
light	  collection	  efficiency	  [168].	  
Out	  of	  focus	  photobleaching	  and	  phototoxic	  effects	  are	  also	  reduced	  due	  to	  the	  inherently	  
confined	   excitation	   volume	   and	   the	   infrared	   light	   is	   less	   harmful	   to	   living	   cells	   and	   tissue	  
[169].	  Moreover,	  as	  fluorescent	  molecules	  has	  relatively	  broad	  and	  overlapping	  two-­‐photon	  
absorption	  spectra	  it	  is	  often	  possible	  to	  excite	  several	  different	  compounds	  with	  the	  same	  
laser,	  while	   keeping	   the	   full	   visible	   spectral	   region	   free	   for	   the	   detection	   of	   the	   emission	  
light	   [170].	   Thus	   TPM	   permits	   straightforward	   multicolor	   imaging,	   e.g	   when	   imaging	   the	  
distribution	  of	  a	   topically	  applied	   compound	   in	   combination	  with	  endogenous	   fluorescent	  
signals	  or	  second	  harmonic	  generations	  [171].	  
In	   this	   work	   two	   different	   TPM	   systems	   have	   been	   used.	   A	   Bio-­‐Rad	   Radiance	   2100MP	  
Rainbow	  confocal	  scanning	  system	  coupled	  to	  an	  inverted	  Olympus	  IX71	  microscope	  and	  a	  
femtosecond	  pulsed	  titanium:sapphire	  laser	  (Tsunami®,	  Spectra-­‐Physics)	  was	  used	  in	  Paper	  
I-­‐IV.	  The	  system	  used	  in	  paper	  V	  was	  a	  Zeiss	  710	   laser	   scanning	   system	  operated	  with	   a	  Axio	  Examiner	  upright	  microscope	  and	  a	  MaiTai	  DeepSeeTM	  femtosecond	  pulsed	  laser.	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Figure	   5.2.	   Schematic	   illustration	   of	   a	   two-­‐photon	   microscope	   including	   a	   pump	   laser,	   a	   pulsed	  
titanium:sapphire	  laser,	  a	  scan	  box	  with	  scanning	  mirrors,	  	  the	  microscope	  with	  objective	  lens,	  direct	  detectors	  	  
and	  descanned	  detectors	  (a).	  Timescales	  for	  the	  generation	  fluorescence	  using	  a	  pulsed	  titanium:saphire	  laser,	  
i.e.	  pulse	  duration	  time	  =	  10-­‐13	  s,	  fluorescence	  =	  10-­‐9	  s	  and	  pulse	  repetition	  rate	  =	  10-­‐8	  s	  (b).	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6 Aims	  and	  objectives	  
	  
This	  thesis	  explores	  different	  aspects	  of	  the	  cutaneous	  absorptions	  and	  distribution	  of	  drugs	  
and	   skin	   sensitizers.	   Specifically,	   TPM	   has	   been	   applied	   to	   get	   mechanistic	   insights	   into	  
processes	   related	   to	   the	   uptake	   of	   xenobiotics	   and	   ACD.	   The	   specific	   aims	   in	   this	   thesis	  
were:	  	  
1.	   To	   investigate	   the	   uptake	   and	   distribution	   of	   a	   hydrophilic	   model	   drug	   following	  
topical	  application	  in	  bicontinuous	  cubic	  phases.	  
2.	   To	  compare	  the	  cutaneous	  uptake	  and	  distribution	  of	  a	  hapten	  and	  a	  non-­‐sensitizing	  
structural	  analogue.	  
3.	   To	   investigate	   the	   sensitization	   potency	   of	   haptens,	   when	   applied	   in	   combination	  
with	  nano-­‐	  and	  micro-­‐scale	  lipid	  vesicles	  
4.	   To	   study	   lipid	   vesicle	   induced	   effect	   on	   the	   skin	   penetration	   and	   percutaneous	  
absorption	  of	  haptens	  in	  relation	  to	  sensitization	  potency.	  
5.	  	   To	  identify	  hapten	  targets	  in	  skin	  using	  caged	  fluorescent	  compounds.	  
6.	   To	   investigate	   phthalate	   induced	   enhancements	   in	   the	   sensitization	   potency	   of	  
isothiocyanates.	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7 Summary	  of	  Papers	  
	  
7.1 Lipid	  cubic	  phases	  in	  topical	  drug	  delivery:	  Visualization	  of	  skin	  
distribution	  using	  two-­‐photon	  microscopy	  (Paper	  I)	  
It	   has	   been	   shown	   that	   MO	   and	   PT	   (Figure	   4.2)	   based	   lipid	   cubic	   phases	   increases	  
aminolevulinic	  acid	  (drug	  used	  in	  photodynamic	  therapy	  of	  skin	  cancer)	  induced	  generation	  
of	   protoporphyrin	   in	   mice	   [128].	   The	   aim	   in	   Paper	   I	   was	   to	   investigate	   the	   uptake	   and	  
distribution	  of	  a	  hydrophilic	  fluorescent	  model	  drug,	  sulforhodamine	  B	  (SRB,	  Figure	  7.1)	   in	  
human	  skin,	  following	  topical	  application	  in	  the	  same,	  MO	  and	  PT	  based	  formulations.	  	  
The	   experiments	   were	   performed	   in	   vitro	   using	   excised	   human	   skin,	   and	   the	   cutaneous	  
absorption	   of	   SRB	   was	   visualized	   using	   TPM.	   The	   uptake	   from	   the	   cubic	   phases	   was	  
compared	   with	   a	   commercial	   ointment	   and	   an	   aqueous	   solution.	   Briefly,	   full-­‐thickness	  
excised	  human	  breast	  skin	  was	  incubated	  for	  24	  h	  with	  test	  formulations	  in	  static	  diffusion	  
cells.	  The	  formulations	  were	  then	  removed	  and	  the	  skin	  was	  mounted	  in	  imaging	  chambers	  
and	  imaged	  by	  TPM.	  	  
The	  cubic	  phases	  was	  shown	  to	  be	  the	  most	  effective	  formulation,	  improving	  the	  uptake	  of	  
SRB,	  as	  compared	  to	  the	  ointment	  and	  the	  aqueous	  solution	  (Figure	  7.1),	  corroborating	  the	  
previous	  results	  by	  Bender	  et	  al	  [128]	  It	  was	  also	  revealed	  that	  SRB	  penetrated	  the	  skin	  via	  
the	  extracellular	  lipid	  matrix	  from	  all	  four	  formulations.	  However,	  the	  distribution	  of	  SRB	  in	  
the	   extracellular	   domain	   differed	   between	   the	   cubic	   phases,	   the	   ointment	   and	   the	  water	  
formulation.	  Two	  separate	  hydrophilic	  penetration	  routes	  were	   identified,	  an	  extracellular	  
and	  an	  intercluster	  pathway.	  Extracellular	  uptake	  was	  predominant	  when	  SRB	  was	  applied	  
in	   the	   water	   formulation	   and	   in	   the	   commercial	   ointment	   as	   seen	   by	   a	   homogenous	  
polyclonal	  distribution	   in	  the	  stratum	  corneum	   (Figure	  7.1).	  Strongly	   fluorescent,	  relatively	  
broad	   transversal	   SRB	   labeled	   regions	  could	  be	  detected	   in	   some	  samples	  exposed	   to	   the	  
commercial	   ointment.	   These	   were	   also	   detected	   in	   samples	   exposed	   to	   the	   MO	   and	   PT	  
based	  cubic	  phases	  and	   is	  believed	  to	  correspond	  to	  deposition	  of	   the	   formulation	   in	  skin	  
wrinkles.	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Figure	   7.1.	  Cutaneous	  distribution	  of	   sulforhodamine	  B	   (SRB,	  a),	   following	   topical	  application	   in	  an	  aqueous	  
solution	  (b)	  and	  a	  MO-­‐based	  lipid	  cubic	  phase	  (c).	  Image	  plane	  323	  ×	  323	  μm.	  	  	  	  
When	   SRB	   was	   applied	   in	   cubic	   phases,	   it	   was	   also	   found	   in	   a	   finer	   network	   of	   micro-­‐
fissures,	  enclosing	  clusters	  of	  corneocytes	  and	  thinner	  thread	  like	  structures.	  Similar	  micro-­‐
structures,	  separating	  clusters	  of	  3	  to	  10	  corneocytes,	  have	  previously	  been	  described	  as	  a	  
potential	  penetration	  pathway	  from	  lipid	  based	  formulations	   in	  mouse	  skin,	  and	  has	  been	  
referred	   to	   as	   the	   intercluster	   pathway	   [149,	   172].	   When	   SRB	   was	   applied	   in	   the	   cubic	  
phases	  it	  penetrated	  relatively	  deep	  into	  these	  fissures	  although	  their	  dimension	  decreased	  
with	  depth.	   	  SRB	  was	  detected	  below	  30	  μm	  in	  50%	  of	   the	  samples	  treated	  with	  the	  MO-­‐
based	  cubic	  formulations	  and	  in	  approximately	  70%	  of	  the	  samples	  exposed	  to	  the	  PT-­‐based	  
cubic	   phases.	   Consequently,	   the	   intercluster	   pathway	  might	   be	   a	   less	   resistant	   route	   for	  
relatively	  deep	  deposition	  of	  hydrophilic	  drugs	  in	  the	  skin.	  It	  is	  possible	  that	  this	  pathway	  is	  
favored	  by	  some	  lipid-­‐based	  delivery	  systems.	  
In	   conclusion,	   the	   previously	   reported	   improved	   delivery	   of	   hydrophilic	   drugs	   using	   cubic	  
phases	  was	   confirmed.	   In	   addition,	   skin	   distribution	   data	   obtained	   by	   TPM	   indicates	   that	  
SRB	  is	  taken	  up	  via	  micro-­‐fissures	  in	  the	  stratum	  corneum,	  which	  could	  act	  as	  a	  reservoir	  for	  
continuous	  release	  of	  drugs	  to	  the	  surrounding	  lipid	  domain	  of	  the	  stratum	  corneum	  and	  to	  
the	  deeper	  skin	  layers.	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7.2 Accumulation	  of	  FITC	  near	  stratum	  corneum	  –	  visualizing	  epidermal	  
distribution	  of	  a	  strong	  sensitizer	  using	  two-­‐photon	  microscopy	  
(Paper	  II)	  
To	   trigger	   an	   immunological	   response	   a	   hapten	   must	   penetrate	   the	   skin	   and	   form	  
immunogenic	   hapten-­‐protein	   complexes	   (Figure	   3.1);	   however,	  where	   exact	   this	   happens	  
and	  the	  nature	  of	  relevant	  hapten	  targets	  has	  not	  been	  elucidated.	  	  The	  aim	  in	  Paper	  II	  was	  
to	  compare	  the	  cutaneous	  uptake	  and	  distribution	  of	  a	  reactive	  hapten	  and	  a	  non-­‐reactive	  
non-­‐sensitizing	   structural	   analogue.	   The	   two	   investigated	   compounds	   were,	   FITC	   and	  
fluorescein	  (Figure	  3.3).	  The	  sensitization	  capacity	  of	  FITC	  and	  fluorescein	  was	  investigated	  
in	   the	  murine	  LLNA	  and	   the	  cutaneous	  and	  percutaneous	  absorption	  were	   investigated	   in	  
vitro	  using	  excised	  human	  skin,	  combining	  diffusion	  cells,	  confocal	  and	  TPM.	  
	  
Figure	  7.2.	  LLNA	  dose	  response	  curves	  for	  FITC	  (Δ,	  EC3	  =	  0.002%)	  and	  fluorescein	  ().	  The	  latter	  was	  found	  to	  
be	   a	   non-­‐sensitizer	   up	   to	   the	   highest	   tested	   concentration	   of	   25%	   (a).	   Confocal	   image	   of	   FITC	   exposed	  
cryosectioned	  skin	  sample	  (b,	  scale	  bar	  =	  50	  μm).	  	  Non-­‐invasive	  TPM	  visualization	  of	  the	  cutaneous	  distribution	  
of	  fluorescein	  (c)	  and	  FITC	  (d)	  in	  excised	  human	  skin	  (image	  plane	  =	  179	  ×	  	  179	  μm).	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The	  results	  revealed	  that	  FITC	  was	  an	  extreme	  sensitizer	  whereas	  fluorescein	  was	  a	  weak	  or	  
non-­‐sensitizer	  up	   to	   the	  highest	   tested	  concentration	   (30%,	  w/v)	   in	   the	  LLNA	   (Figure	  7.2).	  
Though	  an	  extreme	  sensitizer,	  only	  small	  amounts	  of	  FITC	  seemed	  to	  penetrate	  the	  viable	  
compartments	  of	   the	  skin	   (Figure	  7.2).	  While	   fluorescein	   readily	  penetrated	   the	  skin,	  FITC	  
accumulated	  at	  the	  surface,	  in	  the	  stratum	  corneum.	  A	  similar	  distribution	  could	  be	  seen	  in	  
confocal	   images	  of	  cryosectioned	  FITC	  and	   fluorescein	   treated	  samples.	   Interestingly,	  FITC	  
was	   also	   detected	   relatively	   deep	   into	   the	   skin	   inside	   hair	   follicles,	   in	   the	   cryosectioned	  
samples.	  
It	   is	   likely	  that	  the	  reduced	  uptake	  of	  FITC	   is	  due	  to	  conjugation	  to	  macromolecules	   in	  the	  
stratum	  corneum.	  Based	  on	   these	   results	  one	  could	   speculate	   that	   the	   limited	   fraction	  of	  
the	  applied	  dose	   reaching	   the	  viable	   tissue	   is	   enough	   to	   trigger	  an	   immunologic	   reaction.	  
Alternatively,	   it	   is	   possible	   that	   Langerhans	   cells	   in	   the	   boundary	   between	   the	   viable	  
epidermis	   and	   stratum	   corneum	   could	   intercept	   hapten	   protein	   complexes	   formed	   in	   the	  
stratum	   corneum.	   A	   third	   alternative	   is	   that	   uptake	   via	   the	   hair	   follicles	   could	   play	   an	  
important	  alternative	  way	  for	  some	  haptens	  to	  enter	  the	  skin.	  	  
In	  conclusion,	  it	  was	  found	  that,	  although	  FITC	  is	  an	  extreme	  sensitizer	  in	  the	  LLNA,	  it	  does	  
easily	  penetrate	  the	  skin	  barrier.	  Based	  on	  these	  results	  it	   is	  unclear	  if	  only	  low	  amount	  of	  
compound	   reaching	   the	   viable	   epidermis	   is	   enough	   to	   trigger	   an	   immune	   reaction	   or	   if	  
alternative	  mechanisms,	  e.g.	  follicular	  uptake,	  can	  explain	  the	  sensitization	  potency	  of	  FITC.	  	  
	  
7.3 A	  study	  of	  the	  enhanced	  sensitizing	  capacity	  of	  a	  contact	  allergen	  in	  
lipid	  vesicle	  formulations	  (Paper	  III)	  
The	   introduction	   of	   nano-­‐sized	  materials	   in	   topical	   products	   has	   lead	   to	  many	   important	  
improvements	  but	   also	   some	  questions	   regarding	  adverse	  health	  effects.	   Recent	   research	  
indicates	  that	  the	  sensitization	  potency	  of	  haptens	  increases	  when	  applied	  in	  vesicle	  based	  
delivery	   systems	   [173,	   174].	   The	   aim	   in	   Paper	   III	   was	   to	   study	   the	   variations	   in	   the	  
sensitization	  potency	  and	   skin	  penetration	  of	   the	   fluorescent	  model	  hapten	  RBITC	   (Figure	  
3.3)	  when	  applied	  in	  combination	  with	  micro-­‐	  and	  nano-­‐scale	  vesicles	  (ethosomes)	  and	  in	  an	  
ethanol	  in	  water	  (Et:W)	  control	  solution.	  The	  sensitization	  potency	  was	  studied	  in	  vivo	  using	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a	  modified	  non-­‐pooled	  murine	  LLNA	  and	  the	  skin	  penetration	  and	  percutaneous	  absorption	  
was	  analyzed	  ex	  vivo	  using	  diffusion	  cells	  in	  combination	  with	  TPM.	  	  Nano-­‐scale	  vesicles	  (<	  
100	   nm)	   and	  micro-­‐scale	   vesicles	   (>	   1	   μm)	  were	   prepared	   and	   analyzed	   as	   	   described	   in	  
chapter	  4.	  	  
The	  modified	   LLNA	   with	   non-­‐pooled	   lymph	   nodes	   (Figure	   7.3)	   revealed	   an	   almost	   5-­‐fold	  
increase	  in	  the	  lymph	  node	  cell	  proliferative	  response	  when	  RBITC	  was	  applied	  in	  a	  vesicle	  
formulation	  (3579	  ±	  1074	  dpm)	  compared	  to	  when	  it	  was	  applied	  in	  a	  Et:W	  solution	  (643	  ±	  
334	   dpm).	   There	   was	   also	   a	   significant,	   but	   small,	   increase	   in	   the	   lymph	   node	   cell	  
proliferative	   response	  when	  RBITC	  was	  applied	   in	   Et:W	  compared	   to	   the	  negative	   control	  
(409	  ±	  139	  dpm),	  i.e.	  an	  empty	  vesicle	  formulation.	  	  
When	   the	   sensitization	   potency	   of	   RBITC	   was	   investigated	   in	   two	   structurally	   different	  
vesicle	   systems,	   i.e.	   in	   nano-­‐scale	   and	  micro-­‐scale	   vesicles,	   it	   was	   slightly	   increased	   (p	   <	  
0.05)	   in	   the	  micro-­‐scale	   vesicles	   (4913	  ±	   1551	   dpm)	   compared	   to	   the	   nano-­‐scale	   vesicles	  
(3146	  ±	  837	  dpm).	  	  A	  potential	  explanation	  for	  the	  difference	  between	  the	  micro-­‐	  and	  nano-­‐
scale	  vesicle	  formulation	  could	  be	  variations	   in	  the	  concentration	  of	  POPC	  rather	  than	  the	  
structural	   differences	   of	   the	   vesicles.	   It	   was	   found	   that	   approximately	   20	   %	   of	   the	   lipid	  
fraction	  was	  lost	  during	  the	  extrusion	  process,	  thus	  the	  actual	  lipid	  concentration	  was	  20	  %	  
lower	  in	  the	  nano-­‐scale	  formulation	  compared	  to	  the	  micro-­‐scale	  formulation	  tested	  in	  the	  
LLNA.	  This	  assumption	   is	   supported	  by	  previous	   results	  by	  Madsen	  et	  al	   showing	   that	   the	  
sensitizing	  potency	  of	  isoeugenol	  is	  related	  to	  the	  concentration	  of	  POPC	  in	  the	  formulation	  
[174].	  The	  overall	  conclusion	  from	  the	  LLNA	  experiments	  was	  that	  the	  POPC-­‐based	  vesicle	  
formulations	   significantly	   increase	   the	   sensitization	  potency	  of	  RBITC,	  but	   that	   the	   size	  or	  
the	  structure	  of	  the	  vesicles	  has	  a	  less	  significant	  effect.	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Figure	  7.3.	  Non-­‐pooled	  local	  lymph	  node	  assays,	  demonstrating	  the	  relative	  sensitization	  potency	  of	  RBITC	  in	  a	  
nano-­‐scale	  ethosomal	  formulation	  compared	  to	  an	  Et:W	  solution	  (a)	  and	  nano-­‐scale	  compared	  to	  a	  micro-­‐scale	  
ethosomal	  formulation	  (b).	  
	  
Initial	   measurement	   of	   the	   percutaneous	   absorption	   of	   RBITC	   did	   not	   indicate	   any	  
difference	   between	   the	   vesicle	   based	   formulation	   and	   the	   Et:W	   solution.	   However,	   TPM	  
revealed	   that	   both	   nano-­‐scale	   and	   the	  micro-­‐scale	   lipid	   vesicles	   increased	   the	   epidermal	  
uptake	   of	   RBITC	   compared	   to	   the	   Et:W	   solution	   (Figure	   7.4).	   Specifically,	   the	   signal	   was	  
significantly	   increased	  between	  a	  depth	  of	  32	  to	  88	  μm,	  when	  RBITC	  was	  applied	   in	  nano-­‐	  
and	  micro-­‐scale	   ethosomes	   compared	   to	   the	   Et:W	   solution.	   The	   result	   indicates	   that	   the	  
observed	  variations	  in	  the	  sensitization	  potency	  of	  RBITC	  between	  the	  vesicle	  formulations	  
and	  the	  Et:W	  solution	  is	  at	  least	  partly	  a	  consequence	  of	  variations	  in	  the	  cutaneous	  uptake	  
of	  the	  hapten.	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Figure	  7.4.	  Epidermal	  distribution	  of	  RBITC	  following	  topical	  application	  in	  a	  nano-­‐scale	  vesicle	  formulation	  (a),	  
in	  a	  micro-­‐scale	  vesicle	  formulation	  (b)	  and	  in	  an	  ethanol:water	  control	  solution	  (c).	  
	  
There	  was	  no	  difference	  in	  the	  cutaneous	  absorption	  from	  the	  two	  vesicle	  formulations.	  A	  
likely	  explanation	  for	  this	  is	  that	  the	  vesicles	  are	  disrupted	  on	  the	  skin	  surface	  and	  that	  the	  
size	   therefor	   only	   has	   a	  minor	   effect.	   It	   is	   possible	   that	   the	   free	   lipid	  molecules	   act	   as	   a	  
penetration	   enhancers,	   i.e.	   by	   interacting	   with	   the	   lipid	   bilayers	   altering	   the	   solubility	   or	  
diffusion	   coefficient	   of	   RBITC	   in	   the	   SC	   or	   by	   increasing	   the	   vehicle	   to	   stratum	   corneum	  
partitioning	  coefficient.	  
In	   conclusion,	   the	   results	   presented	   in	   Paper	   III,	   shows	   that	   the	   sensitization	   potency	   of	  
RBITC	   increases	   when	   applied	   in	   nano	   and	  micro-­‐scale	   ethosomes	   compared	   to	   an	   Et:W	  
solution.	  In	  combination	  with	  the	  results	  by	  Madsen	  et	  al	  this	  implies	  a	  general	  increase	  in	  
the	   sensitization	  potency	  of	  haptens	   applied	   in	   vesicle	   formulations.	  However,	   nano-­‐scale	  
vesicles	  do	  not	  seems	  to	  have	  any	  increased	  adverse	  effect	  compared	  to	  larger	  micron-­‐scale	  
vesicles.	  The	  sensitization	  enhancing	  effect	  of	  the	  vesicle	  formulations	  is	  likely	  related	  to	  an	  
improved	  penetration	  of	  the	  haptens	  from	  these	  vehicles.	  Still,	   further	  studies	  are	  needed	  
before	   a	  more	   general	   conclusion	   can	   be	   drawn	   regarding	   the	   risk	   of	   being	   sensitized	   in	  
combination	  with	  exposure	  to	  vesicle	  based	  formulations.	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7.4 Caged	  Fluorescent	  Haptens	  Reveal	  the	  Generation	  of	  Cryptic	  Epitopes	  
in	  Allergic	  Contact	  Dermatitis	  (Paper	  IV)	  	  
The	  location	  of	  hapten	  protein	  targets	  (e.g.	  intra	  cellular,	  membrane	  bound	  or	  extra	  cellular	  
proteins)	   and	   the	   molecular	   identity	   of	   the	   immunogenic	   hapten-­‐protein	   complexes	   and	  
corresponding	  epitopes	  have	  not	  been	  elucidated.	  In	  Paper	  IV,	  a	  group	  of	  caged	  fluorescent	  
compounds,	   i.e.	   bromobinanes	   (Figure	   3.3),	   were	   topically	   applied	   and	   followed	   using	   a	  
combination	  of	  fluorescence	  microscopy,	  proteomics	  and	  mass	  spectrometry,	  with	  the	  aim	  
to	  identify	  their	  protein	  targets.	  	  
It	  was	  presumed	  that	  the	  thiol	  reactive	  bromobimanes	  were	  potential	  sensitizers.	  However,	  
before	  any	  further	  studies	  could	  be	  conducted,	  this	  had	  to	  be	  verified	  experimentally.	  Thus,	  
skin	   sensitization	  potency	  of	  mBBR,	  dBBR	  and	  a	  non-­‐reactive	  negative	   control	   compound,	  
syn-­‐(methyl,methyl)bimane,	  was	  tested	  in	  the	  LLNA	  (Figure	  7.5	  a).	  The	  LLNA	  result	  revealed	  
that	  both	  mBBR	  (EC3	  =	  0.12%)	  and	  dBBR	  (EC3	  =	  0.17%)	  were	  strong	  sensitizers	  while	  syn-­‐
(methyl,methyl)bimane	  was	  a	  non-­‐sensitizer	  up	  to	  a	  concentration	  of	  2.5%.	  
The	   localization	  of	  hapten	   targets	  was	   initially	  visualized	  by	  TPM,	  which	   revealed	   that	   the	  
bromobimanes	   reacted	  with	  proteins	  or	  peptides	   in	  stratum	  corneum	   (Figure	  7.5).	  With	  a	  
relatively	   high	   concentration	   of	   the	   hapten	   in	   combination	   with	   a	   high	   abundance	   of	  
nucleophilic	  amino	  acids,	  peptides	  and	  partially	  degraded	  proteins	  in	  the	  stratum	  corneum	  
[175,	  176]	  it	  is	  not	  surprising	  to	  find	  extensive	  hapten-­‐protein	  conjugations	  in	  this	  skin	  layer.	  
However,	  the	  immunological	   implication	  for	  the	  formation	  of	  hapten	  protein	  complexes	  in	  
stratum	  corneum	  is	  unclear.	  TPM	  imaging	  also	  revealed	  that	  the	  bromobimanes	  penetrated	  
and	  reacted	  with	  cells	   in	  the	  viable	  epidermis.	  A	  bit	  surprising,	  the	  bromobimanes	  did	  not	  
primarily	  react	  with	  the	  suprabasal	  cells,	  as	  seen	  by	  a	  relatively	  weak	  fluorescence	  signal	  in	  
the	   stratum	   spinosum.	   Instead,	   TPM	   images	   indicated	   that	   basal	   cells	   were	   the	   primary	  
targets	   in	   the	   viable	   epidermis.	   This	   result	   was	   supported	   by	   confocal	   imaging	   of	  
cryosectioned	  bimane	  treated	  skin	  samples.	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Figure	   7.5.	   LLNA	   dose	   response	   curves	   for	   mBBr	   (EC3	   =	   0.12%,	   Δ),	   dBBr	   (EC3	   =	   0.17%,	   )	   and	  
syn(methyl,methyl)bimane	  (×).	  Three-­‐dimensional	  visualization	  of	  the	  epidermal	  distribution	  of	  mBBr	  (b)	  and	  
dBBR	  (c)	  protein	  targets.	  Optical	  z-­‐cross	  section	  of	  a	  mBBr	  exposed	  sample	  (d)	  and	  a	  dBBr	  exposed	  sample	  (e).	  	  
Lateral	  distribution	  of	  mBBr	  (f,	  z	  =	  52	  μm)	  and	  dBBr	  (g,	  z	  =	  62	  μm)	  in	  or	  adjacent	  to	  the	  basal	  cell	  layer.	  	  
	  
Initially,	   it	   was	   suspected	   that	   the	   fluorescent	   cells	   were	   epidermal	   Langerhans	   cells.	  
However	   an	   immunohistochemical	   analysis	   of	   cryosectioned	   skin	   samples	   using	   CD1a,	   K5	  
and	  K14	  antibodies,	  excluded	  the	  Langerhans	  cells	  and	   indicated	   that	   the	  bimane	   labelled	  
cells	   corresponded	   to	   basal	   cell	   keratinocytes.	   This	   was	   later	   supported	   by	   both	  western	  
blot	   and	   mass	   spectrometry	   analysis.	   Another	   observation	   made	   in	   both	   the	   TPM	   and	  
confocal	   images,	  was	   that	   the	  bromobimanes	  did	  not	   label	  all	   cells	   in	   the	  basal	   cell	   layer.	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Instead	   clusters	   of	   bimane-­‐labelled	   cells	   were	   detected.	   The	   clustered	   pattern	   led	   to	   a	  
hypothesis	  that	  the	  labelled	  cells	  might	  be	  epidermal	  stem	  cells,	  which	  have	  been	  shown	  to	  
reside	  in	  stem	  cell	  niches,	  i.e.	  clusters	  in	  the	  basal	  cell	  layer	  [177,	  178].	  The	  exact	  reason	  for	  
patchy	   distribution	   of	   the	   bimane	   labelled	   cells	   was	   not	   further	   investigated,	   thus	   the	  
reason	  for	  the	  irregular	  lateral	  distribution	  of	  the	  bimane	  labelled	  cells	  remains	  speculative.	  	  
To	   identify	   the	  protein	   targets,	  protein	  extracts	   from	  skin	  samples	   incubated	  with	  bimane	  
formulations	  were	   prepared	   and	   separated	   by	   SDS-­‐PAGE.	   The	   strongest	   fluorescent	   band	  
from	  the	  mBBr	  treated	  sample	  had	  a	  molecular	  weight	  of	  approx.	  60	  kDa	  and	  the	  strongest	  
fluorescent	  band	  in	  the	  dBBr	  treated	  sample	  had	  a	  molecular	  weight	  of	  approx.	  110	  kDa.	  In	  
combination	   with	   the	   results	   from	   the	   TPM	   and	   the	   Immunohistochemical	   analysis,	  
demonstrating	   that	   basal	   keratinocytes	   were	   hapten	   targets,	   it	   was	   speculated	   that	   the	  
protein	  band	  around	  60	  kDa	  corresponded	  to	  K5	  (58	  kDa)	  and	  that	  the	  band	  at	  around	  100	  
kDa	  could	  be	  cross-­‐linked	  K5	  or	  K14	  monomers	  (100	  or	  116	  kDa),	  alternatively	  cross-­‐linked	  
K5/K14	  heterodimers	  (108	  kDa).	  A	  Western	  Blot	  confirmed	  this	  hypothesis.	  
The	  most	  intense	  protein	  bands	  in	  the	  SDS-­‐PAGE	  gels	  were	  excised	  and	  analyzed	  by	  tandem	  
mass	  spectrometry.	  A	  Mascot	  search	  corroborated	  the	  previous	  identification	  of	  K5	  and	  K14	  
as	   hapten	   targets	   in	   the	   skin.	   K5	   was	   positively	   identified	   in	   the	   58	   kDa	   band	   from	   the	  
analysis	  of	  the	  mBBr	  treated	  sample	  and	  both	  K5	  and	  K14	  were	  present	  in	  the	  excised	  band	  
from	   the	   dBBr	   treated	   sample.	   In	   addition,	   manual	   interpretation	   of	   the	   tandem	   mass	  
spectrometry	  data	  revealed	  a	  tryptic	   fragment	   (V48	  to	  R62,	  Figure	  7.6)	  with	  a	  haptenated	  
cysteine	   residue	   (C54).	   Subsequent,	   analysis	   of	   the	   fragmentation	   pattern	   of	   the	  MS/MS	  
spectra	  confirmed	  the	  modification	  on	  C54.	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Figure	   7.6.	   Tandem	  mass	   spectra	   of	   the	   tryptic	   fragment	   (V48	   to	   R62)	   of	   keratin	   5	   with	   a	   mBBr	  modified	  
cysteine	  (C54).	  
	  
In	   conclusion,	   a	   combination	   of	   caged	   fluorescent	   haptens,	   fluorescent	   microscopy,	  
immunohistochemistry	   and	   proteomics	   led	   to	   the	   identification	   basal	   keratinocytes	   and	  
specifically	   the	   keratins	   K5	   and	   K14	   as	   potential	   hapten	   targets	   in	   human	   skin.	   A	   hapten	  
modification	  of	  the	  residue	  C54	  on	  K5	  was	  also	   identified.	  The	  result	  highlights	  the	  role	  of	  
the	  keratinocytes	  and	  the	  keratins	  in	  ACD.	  
	  
7.5 The	  pilosebaceous	  unit	  –	  a	  phthalate-­‐induced	  highway	  to	  skin	  
sensitization	  (Paper	  V)	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8 	  General	  Discussion	  
	  
The	   development	   of	   efficient	   epicutaneous	   drug	   delivery	   systems	   rely	   on	   a	   fundamental	  
understanding	  of	  the	  skin	  barrier	  and	  its	  interaction	  with	  topically	  applied	  compounds	  and	  
formulations.	   This	   is	   equally	   important	   when	   evaluating	   biologic	   effects	   following	   topical	  
exposure	   to	  harmful	   xenobiotics,	  e.g.	   skin	   sensitizers.	  A	  central	   component	   in	  all	   research	  
and	   development	   are	   tools	   to	   measure	   and	   analyze	   specific	   processes	   and	   effects.	   TPM	  
offers	  unique	  possibilities	   to	  study	   the	  relative	  uptake,	  penetration	  pathways,	   skin	   targets	  
and	  depot	  effects	  of	  topically	  applied	  fluorescent	  compounds	  relatively	  deep	  into	  intact	  skin	  
samples,	   giving	   valuable	   information	   about	   the	   interactions	   between	   the	   skin	   and	  
xenobiotics.	  The	  application	  of	  TPM	  within	  the	  work	  of	  this	  thesis	  has	  provided	  new	  insights	  
in	   drug	   delivery	   as	   well	   as	   mechanisms	   involved	   in	   contact	   allergy,	   as	   will	   be	   discussed	  
below.	  In	  addition,	  a	  discussion	  of	  the	  methods	  chosen	  will	  be	  provided,	  along	  with	  a	  final	  
conclusion	  and	  some	  future	  perspectives.	  
8.1 New	  insights	  in	  drug	  delivery	  
The	  improved	  cutaneous	  uptake	  from	  lipid	  cubic	  phases	  applied	  to	  human	  skin	  offers	  clinical	  
applications	   due	   to	   the	   penetration	   enhancing	   effect	   of	   these	   formulations.	   In	   this	  work,	  
TPM	   provided	   supplementary	   data	   regarding	   the	   cutaneous	   distribution	   and	   skin	  
penetration	   pathways.	   A	   putative	   mechanistic	   explanation	   for	   the	   observed	   penetration	  
enhancing	  effect	  of	  the	  cubic	  phases	  could	  be	  proposed	  based	  on	  the	  penetration	  pathways	  
observed.	   	   In	  a	  broader	  perspective,	  better	   insight	   into	  drug	  uptake	  and	  distribution	  using	  
TPM	   could	   improve	   interpretation	   of	   pharmacokinetic	   effects	   and	   support	   in	   future	  
development	  and	  improvements	  of	  topical	  formulations.	  It	  could	  also	  assist	  in	  the	  choice	  of	  
vehicle	  depending	  on	  target	  tissue.	  Specifically,	  cosmetic	  products	  are	  generally	  intended	  to	  
target,	  either	  the	  skin	  surface	  or	  the	  stratum	  corneum.	  Penetration	  to	  the	  deeper	  skin	  layer	  
is	  often	  undesirable	  and	  vehicle	   induced	  penetration	  enhancing	  effects	  might	   increase	  the	  
risk	  of	  adverse	  health	  effects.	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8.2 New	  insights	  in	  contact	  allergy	  
8.2.1 Vehicle	  effects	  on	  the	  sensitization	  potency	  of	  haptens	  
The	  LLNA	  revealed	  significant	  vehicle	  induced	  variations	  in	  sensitization	  potency	  of	  haptens.	  
Specifically,	  the	  results	  showed	  that	  isothiocyanates	  are	  extreme	  sensitizers	  when	  applied	  in	  
combination	  with	  phthalate	  (DBP)	  but	  non-­‐	  or	  weak	  sensitizers	  when	  applied	  in	  e.g.	  DMSO.	  	  
There	  is	  a	  general	  correlation	  between	  bioavailability	  and	  biological	  effects.	  However,	  FITC	  
did	  not	  seem	  to	  penetrate	  the	  skin	  when	  applied	  in	  combination	  with	  DBP	  (Paper	  II),	  at	  least	  
not	  via	  the	  stratum	  corneum.	  An	  alternative	  penetration	  pathway	  via	  the	  hair	  follicles	  was	  
hypothesized	  based	  on	  confocal	  microscopy	  of	  cryosectioned	  human	  skin	  samples	  exposed	  
to	  FITC.	  This	  pathway	  was	  later	  clearly	  identified	  as	  major	  contributor	  to	  the	  cutaneous	  and	  
percutaneous	  absorption	  of	  both	  RBITC	  and	  FITC	  when	  applied	  in	  combination	  with	  DBP	  in	  
vivo	   in	  mouse	  (Paper	  V).	  Compared	  to	  the	  absorption	  of	  RBITC	   in	  acetone	  and	  DMSO,	  the	  
target	   specific	   delivery	   via	   the	   PSU	   appears	   as	   a	   likely	   explanation	   for	   the	   increased	  
sensitization	  potency	  of	  isothiocyanates	  in	  the	  LLNA.	  
In	  Paper	  III	  it	  was	  found	  that	  the	  increased	  sensitization	  potency	  of	  RBITC	  correlated	  with	  an	  
improved	  general	   cutaneous	  absorption	   in	  excised	  human	  skin,	  but	  no	   specific	  uptake	  via	  
the	   hair	   follicles	   was	   detected.	   A	   preliminary	   experiment	   in	   connection	   with	   the	   study	  
presented	   in	  Paper	  V,	   indicated	   that	  ethosomal	   formulations	  also	   improves	   the	  uptake	  of	  
RBITC	  into	  the	  pilosebaceous	  units	  compared	  to	  the	  control	  vehicle,	  in	  vivo	   in	  mouse	  (data	  
not	   shown).	   Thus	   there	   seems	   to	   be	   a	   connection	   between	   follicular	   absorption	   and	  
sensitization	  potency	  also	  in	  this	  case.	  
The	  PSUs	  have	  traditionally	  not	  been	  considered	  to	  play	  any	  significant	  role	  in	  the	  uptake	  of	  
topically	   applied	   compounds.	   However,	   new	   studies	   indicate	   that	   follicular	   transport	   has	  
been	  underestimated	  and	  hair	  follicles	  have	  become	  attractive	  targets	  in	  epicutaneous	  drug	  
delivery	  [24,	  28,	  182,	  183].	  	  The	  PSU	  have	  so	  far	  not	  been	  widely	  discussed	  as	  a	  mediator	  of	  
CHS	  reactions,	  although	  it	  could	  be	  regarded	  as	  an	  ideal	  route	  for	  hapten	  to	  penetrate	  the	  
viable	   compartments	   of	   the	   skin,	   bypassing	   the	   stratum	   corneum.	   In	   addition,	   the	  
surrounding	   tissue	  has	  a	   relatively	  high	  abundance	  of	   immune	  cells,	   i.e.	  dendritic	   cells,	   T-­‐
cells	  and	  macrophages	  [25,	  26].	  The	  PSU	  is	  also	  the	  skins	  largest	  reservoir	  of	  stem	  cells	  [9]	  
and	   it	   has	   a	   closely	   connecting	   extensive	   network	   of	   perifollicular	   capillaries,	   enabling	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effective	   systemic	   resorption	   of	   compounds	   absorbed	   via	   the	   PSU	   [28].	   Moreover,	  
compounds	  stuck	   in	   the	   follicle	  orifice	  will	   likely	   reside	   in	   the	  skin	   for	   longer	   time	  periods	  
compared	  to	  compounds	  trapped	  in	  the	  stratum	  corneum	  [24].	  The	  reservoir	  capacity	  of	  the	  
PSU	   could	   have	   a	   role	   in	   e.g.	   primary	   ACD	   reactions	   [184].	   It	   is	   also	   likely	   that	   repeated	  
contact	  with	  non-­‐sensitizing	  doses	  of	  hapten	  accumulating	   in	  the	  PSUs	  eventually	   leads	  to	  
sensitizing	   concentrations	   in	   the	   skin.	   Repeated	   exposure	   is	   an	   important	   predisposing	  
factor	  in	  ACD	  [185].	  	  
Being	  a	  well-­‐known	  penetration	  enhancer,	  DMSO	  was	  chosen	  as	  one	  of	  the	  control	  vehicles	  
in	  Paper	  V.	  Considering	  its	  capacity	  to	  improve	  the	  uptake	  of	  topically	  applied	  compounds,	  it	  
was	   initially	   surprising	   to	   find	   that	  RBITC	  did	  not	   induce	   any	  proliferative	   response	   in	   the	  
LLNA	   in	   DMSO.	   It	   was	   even	  more	   surprising	   that	   RBITC	   did	   not	   penetrate	   the	   skin	  more	  
when	   applied	   in	   this	   vehicle.	   A	   reactivity	   assay	   suggested	   that	   DMSO	   provokes	   a	   rapid	  
conjugation	  of	  RBITC	  to	  proteins	  in	  the	  upper	  stratum	  corneum,	  which	  limits	  the	  uptake	  of	  
RBITC	   into	   the	   skin.	   Thus,	   vehicle	   induced	   variations	   in	   reactivity	   towards	   skin	   surface	  
proteins	  should	  be	  considered	  as	  a	  regulating	  factor	  when	  exploring	  the	  uptake	  of	  reactive	  
compounds	  like	  sensitizers.	  	  
Taken	   together,	   the	   results	   indicate	   that	   isothiocyanates,	   due	   to	   their	   reactivity,	   do	   not	  
readily	  penetrate	  the	  skin	  directly	  via	  the	  stratum	  corneum,	  except	  perhaps	  if	  applied	  in	  very	  
high	  concentrations.	  Thus	  these	  compounds	  need	  an	  alternative	  route	  of	  entry	  into	  the	  skin	  
to	   induce	   an	   allergic	   response;	   e.g.	   via	   shunts	   or	   via	   damaged	   skin.	   Uptake	   via	   the	   PSUs	  
seems	   to	   be	   facilitated	   in	   combination	   with	   DBP.	   The	   results	   also	   reveal	   that	   vehicle	  
dependent	  hapten	   reactivity	   towards	   stratum	  corneum	   proteins	   regulates	   the	  uptake	  and	  
thus	  the	  potency	  of	  the	  hapten.	  
It	  is	  important	  to	  point	  out	  that	  modifications	  in	  the	  chemical	  composition	  of	  the	  vehicle	  can	  
have	  other	  consequences,	  which	  might	   influence	  the	  potency	  of	  the	  haptens.	  For	  example	  
phthalate	  or	  POPC	  induced	  adjuvant	  effects,	  i.e.	  induction	  of	  inflammatory	  mediators,	  have	  
not	  been	  investigated	  here,	  and	  can	  therefore	  not	  be	  ruled	  out.	  	  
Regardless	  of	  the	  mechanism	  behind	  the	  vehicle-­‐induced	  variations,	  the	  results	  emphasise	  
the	   importance	   to	   consider	   formulation	   effects	   when	   evaluating	   the	   potency	   of	   skin	  
sensitizer.	   Variation	   in	   the	   sensitizing	   capacity	   due	   to	   formulation	   effects	   should	   be	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considered	  when	  performing	  risk	  evaluation	  based	  on	  the	  LLNA	  EC3	  value.	  Similarly,	  vehicles	  
effects	  should	  also	  be	  considered	  when	  performing	  patch	  tests	  of	  ACD	  patients.	  	  
8.2.2 Identification	  of	  hapten	  targets	  	  
One	   of	   the	   great	   challenges	   in	   the	   research	   related	   to	   contact	   allergy	   is	   to	   identify	  
immunogenic	  hapten-­‐protein	  complexes	  and	  the	  nature	  of	  the	  modification	  of	  the	  protein	  
targets.	  Considering	  the	  amount	  of	  protein	  targets	  in	  the	  skin,	  this	  might	  be	  like	  looking	  for	  
a	   needle	   in	   a	   haystack.	   In	   Paper	   IV,	   a	   combination	   of	   caged	   fluorescent	   haptens,	   TPM,	  
proteomics	  and	  mass	  spectrometry	  led	  to	  the	  first	  published	  identification	  of	  a	  haptenation	  
site	   in	  human	  skin	   tissue.	  The	   thiol	   reactive	  bromobimanes	   specifically	   reacted	  with	  basal	  
keratinocytes	   and	   the	   keratins	   K5	   and	   K14.	   Furthermore	   C54	   on	   K5	   was	   identified	   as	   a	  
hapten	  target.	  
Structural	   and	   chemical	   variations	   in	   the	   differentiating	   epidermal	   keratinocytes	   could	   be	  
one	  reason	  for	  the	  specific	  reactivity	  of	  the	  bromobimanes	  with	  the	  basal	  keratinocytes.	  A	  
reactivity	   assay	   revealed	   that	   bromobimanes	   readily	   reacts	   with	   thiols	   but	   not	   with	  
disulfides.	   Thus,	   hapten	   targets	   in	   the	   skin	   should	   be	   expected	   to	   be	   free	   thiols.	   The	  
relatively	  high	  abundance	  of	  available	   free	   thiols	   in	   the	  basal	   compared	   to	   the	  suprabasal	  
keratinocytes,	   where	   the	   sulfhydryles	   are	   concealed	   due	   to	   extensive	   bundling	   of	   the	  
keratins	  and	  cross	  linking	  of	  the	  cysteines,	  could	  lead	  to	  a	  more	  intense	  labelling	  of	  the	  basal	  
cell	   layer.	  A	  similar	  localisation	  have	  previously	  been	  observed	  in	  studies	  on	  the	  epidermal	  
distribution	  of	  DNCB,	  another	  thiol	  reactive	  skin	  sensitizer	  [186].	  	  
Based	  on	   the	   results	   in	  Paper	   IV,	   further	   investigations	  has	  been	   conducted	   in	   vitro	   using	  
cultured	   human	   keratinocytes	   [187].	   Incubation	   with	   the	   bromobimanes	   led	   to	   a	   rapid	  
internalization	   of	   the	   haptens	   and	   labelling	   of	   structures	   resembling	   the	   keratin	  
intermediate	   filaments.	   In	   addition,	   the	   keratinocytes	   responded	   by	   forming	   fluorescent	  
membrane	  vesicles	  (blebs).	  It	  could	  be	  shown	  that	  the	  vesicles	  contained	  both	  haptenated	  
K5	  and	  K14.	  The	  specific	  labelling	  of	  C54	  in	  K5	  could	  also	  be	  confirmed.	  As	  C54	  is	  part	  of	  the	  
head-­‐region	   of	   K5,	   which	   binds	   to	   desmoplakin	   and	   the	   desmosomes,	   an	   interesting	  
speculation	  would	  be	  if	  haptenation	  could	  lead	  to	  malfunction	  of	  the	  desmosome	  complex	  
and	  subsequently	  the	  keratinocyte.	  The	  outcome	  of	  this	  malfunction	  could	  perhaps	  result	  in	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the	  release	  of	  non-­‐self	  immunogenic	  keratin-­‐epitopes	  in	  membrane	  vesicles;	  however,	  this	  
has	  yet	  to	  be	  demonstrated	  in	  vivo.	  
The	   new	   restrictions	   of	   the	   use	   of	   animal	   based	   toxicity	   assays,	   e.g.	   using	   the	   LLNA	   for	  
predicting	  the	  sensitization	  potency	  of	  haptens,	  has	  led	  to	  an	  urgent	  need	  for	  new	   in	  vitro	  
based	  assays,	  as	  discussed	  in	  chapter	  3.	  Thus,	  the	  results	  obtained	  within	  this	  project	  have	  
stimulated	   to	   further	   investigation	   whether	   the	   keratinocyte	   response,	   i.e.	   the	   blebbing,	  
could	   be	   used	   as	   an	   alternative	   in	   vitro	   assay	   to	   test	   the	   sensitization	   potency	   of	   skin	  
sensitizers	  [188].	  
8.3 The	  choice	  of	  skin	  model	  
In	   four	   out	   of	   five	   papers	   included	   in	   this	   thesis,	   skin	   penetration	   experiments	   were	  
performed	   in	  vitro	  using	  excised	  human	  skin,	  obtained	  from	  breast	  reduction	  surgery.	  The	  
skin	  was	  stored	  at	  -­‐70	  °C	  up	  to	  3	  month	  before	  it	  was	  used.	  Penetration	  studies	  using	  TPM	  
were	   carried	   out	   using	   full	   thickness	   skin	   samples	   and	   permeation	   experiments	   were	  
conducted	   using	   heat	   separate	   epidermal	   sheets.	   In	   either	   case,	   viability	   was	   not	  
maintained	   in	   these	   assays.	   This	   is	   generally	   not	   an	   issue,	   assuming	   uptake	   is	   a	   passive	  
diffusive	  process	  and	  stratum	  corneum	  being	  the	  rate	  limiting	  membrane.	  	  However,	  some	  
artefacts	   e.g.	   due	   to	   heat-­‐separation	   cannot	   be	   ruled	   out.	   Evaluating	   the	   integrity	   of	   the	  
isolated	   epidermal	   sheets,	   e.g.	  measuring	   electrical	   resistance,	  might	   be	   appropriate,	   but	  
has	   not	   been	   performed	   in	   these	   studies.	   Reconstructed	   skin	   is	   an	   interesting	   viable	  
alternative;	  however	  cases	  of	  deviations	   in	  permeability	  compared	  to	   isolated	  human	  skin	  
has	  been	   reported.	  Moreover,	   reconstructed	   skin	  models	  do	  not	   include	   shunts	  pathways	  
and	  potential	  effects	  of	  the	  circulatory	  system.	  Although	  mouse	  models	  (Paper	  V),	  provides	  
in	  vivo	  setting,	  differences	  in	  the	  architecture	  of	  mouse	  and	  human	  skin,	  e.g	  thickness	  and	  
follicle	  density,	  must	  be	  considered.	  	  
8.4 Two-­‐photon	  microscopy	  of	  the	  skin,	  benefits	  and	  limitations	  
TPM	   offers	   a	   unique	   possibility	   to	   explore	   the	   interactions	   between	   the	   skin	   and	  
xenobiotics,	   e.g.	   skin	   sensitizers,	   and	   cutaneous	   immunological	   reactions	   in	   or	   close	   to	   in	  
vivo	  conditions.	  It	  is	  also	  an	  interesting	  method	  to	  study	  topical	  drug	  delivery.	  TPM	  provides	  
information,	   which	   would	   be	   difficult	   to	   extract	   from	   more	   traditional	   techniques,	   e.g.	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regarding	   local	   absorption	   and	   targeted	   delivery.	   Compared	   to	   confocal	  microscopy,	   TPM	  
provides	   an	   improved	   imaging	   depth	   and	   a	  more	   straightforward	   approach	   to	  multicolor	  
imaging.	   Multiple	   fluorophores,	   both	   endogenous	   and	   exogenous,	   and	   single	   harmonic	  
generation	   can	   be	   visualized	   using	   a	   single	   laser.	   This	   facilitates	   imaging	   of	   the	   skin	  
morphology	  when	  e.g.	  studying	  the	  absorption	  of	  topically	  applied	  compounds.	  	  
However,	   imaging	   depth	   is	   not	   unlimited	   and	   lack	   of	   knowledge	   regarding	   signal	   losses	  
makes	   absolute	   quantification	  more	   or	   less	   impossible.	   In	   addition,	   high	   concentration	   of	  
fluorophores	  at	  the	  skin	  surface,	  which	  is	  a	  common	  situation	  when	  studying	  the	  cutaneous	  
absorption	   of	   topically	   applied	   compounds,	   seems	   to	   generate	   ‘ghost’	   signals	   which	   can	  
complicate	   the	   imaging	   of	   the	   deeper	   skin	   layers.	   Furthermore,	   the	   vertical	   resolution	   is	  
generally	  better	  when	  imaging	  cryo-­‐sectioned	  skin	  samples,	  though	  at	  the	  cost	  of	  a	  reduced	  
field	  of	  view	  and	  an	  increased	  risk	  for	  artifacts	  and	  sample	  contamination.	  A	  drawback	  using	  
this	  technique	  is	  that	  only	  fluorescent	  model	  drugs	  or	  haptens	  can	  be	  visualized.	  Antibodies	  
can	  be	  used	  on	  sectioned	  skin,	  but	  their	  utility	  is	  limited	  in	  thick	  samples.	  
An	   important	   limitation	   of	   the	   TPM	   technique	   to	   analyze	   the	   cutaneous	   absorption	   of	  
topically	   applied	   compounds	   is	   the	   incapacity	   to	   determine	   absolute	   fluorophore	  
concentrations	   in	   tissue.	   	   Only	   relative	   estimations	   of	   the	   concentration	   of	   the	   same	  
compound	   at	   a	   specific	   depth	   can	   be	   done.	   It	   is	   difficult	   to	   e.g.	   compare	   the	   cutaneous	  
absorption	  of	  two	  different	  compounds	  or	  the	  relative	  concentration	  of	  a	  single	  compound	  
at	  to	  different	  depth	  in	  the	  skin.	  One	  possible	  solution	  to	  this	  problem	  is	  the	  combination	  of	  
TPM	  and	  fluorescence	  correlation	  spectroscopy,	  i.e.	  a	  technique	  referred	  to	  as	  two-­‐photon	  
fluorescence	  correlation	  microscopy.	  By	  measuring	  the	  fluctuations	  of	  fluorescent	  signal	   in	  
the	   subfemtoliter	   two-­‐photon	  excitation	  volume	   it	   is	  possible	   to	  determine	  both	  absolute	  
concentrations	  and	  diffusion	  constants	  of	  fluorescent	  molecules	  in	  in	  the	  skin	  [189].	  
Despite	  the	  limitations	  mentioned	  above,	  TPM	  has	  opened	  up	  a	  unique	  opportunity	  to	  study	  
biological	   processes	   in	   real	   time	   in	   living	   animals.	   In	   vivo	   and	   intra	   vital	   TPM	   has	  
consequently	  attracted	  a	   lot	  of	   interest	   in	   the	   last	  years,	   in	  particularly	  within	   the	   field	  of	  
immunology.	  	  The	  skin	  penetration	  studies	  included	  in	  thesis	  were	  performed	  either	  in	  vitro	  
using	   excised	   human	   skin	   or	   combining	   in	   vivo	   exposure	   and	   ex	   vivo	   imaging	   (Paper	   V).	  
While	  the	  experimental	  design	  used	  in	  e.g.	  Paper	  V	  is	  practical	  and	  provide	  the	  possibility	  to	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image	  several	  samples	  at	  the	  same	  occasion,	  it	  does	  not	  provide	  a	  dynamic	  view	  of	  what	  is	  
happening	   in	   the	   skin.	   Thus	   for	   a	   more	   detailed	   and	   complete	   picture	   of	   the	   processes	  
related	  to	  exposure	  to	  skin	  sensitizers	  and	  the	   faith	  of	  a	  hapten	   in	  a	   living	  system,	   in	  vivo	  
and	  intra	  vital	  techniques	  should	  be	  further	  investigated.	  	  
	  
8.5 Conclusions	  and	  future	  outlooks	  
In	  this	  thesis,	  TPM	  has	  been	  used	  to	  analyze	  the	  cutaneous	  absorption	  and	  distribution	  of	  a	  
model	  drug	  and	  a	  series	  of	  model	  skin	  sensitizers.	  A	  potential	  mechanistic	  explanation	  for	  
the	   penetration	   enhancing	   effect	   of	   lipid	   cubic	   phases	   has	   been	   proposed	   and	   the	   first	  
confirmed	  hapten	  amino	  acid	  target	  in	  skin	  has	  been	  identified	  based	  on	  studies	  using	  TPM.	  
Moreover,	   vehicle	   induced	   variations	   in	   the	   sensitization	   potency	   of	   haptens	   has	   been	  
revealed	   in	   the	   LLNA.	   Specifically,	   the	   increased	   sensitization	   potency	   of	   isothiocyanates	  
applied	   in	   combination	  with	   phthalates	   could	   be	   linked	   to	   a	   PSU-­‐targeted	   delivery	   of	   the	  
haptens.	   It	   could	  also	  be	   shown	   that	  vehicles	  alters	  hapten	   reactivity	   to	  stratum	  corneum	  
proteins	  and	   that	   this	   can	   lead	   to	   significant	  variations	   in	   sensitization	  potency.	  Together,	  
these	  results	  demonstrate	  some	  of	  the	  potentials	  of	  implementing	  TPM	  into	  investigations	  
of	  the	  interactions	  between	  the	  skin	  and	  xenobiotics.	  
In	   the	   future	   in	   vivo	   and	   intra	   vital	   techniques	   should	   be	   further	   investigated	   to	   study	  
processes	  related	  to	  exposure	  to	  skin	  sensitizers	  and	  the	  faith	  of	  haptens	  in	  a	  living	  systems.	  	  
Specifically,	   some	   of	   the	   findings	   presented	   in	   this	   thesis	   should	   be	   interesting	   to	  	  
investigate	   further	   in	   an	   in	   vivo	   model,	   e.g.	   the	   uptake	   caged	   fluorescent	   compounds.	  
Moreover,	   improvements	   in	   two-­‐photon-­‐fluorescence	   correlation	   spectroscopy	   have	   the	  
potential	   to	  give	  a	  new	  perspective	  on	  the	   interactions	  between	  xenobiotics	  and	  the	  skin.	  
The	  possibility	  to	  determine	  exact	  concentrations	  and	  diffusion	  constants	  of	  model	  drugs	  in	  




	   59	  
In	  conclusion,	  the	  work	  presented	  in	  this	  thesis	  contributes	  to	  the	  general	  understanding	  of	  
the	  mechanisms	  involved	  in	  the	  cutaneous	  absorption	  of	  topically	  applied	  drugs.	  It	  also	  puts	  
contact	   allergy	   in	   a	   new	   focus,	   using	   TPM	   to	   image	   cutaneous	  uptake	   and	   distribution	  of	  
haptens	  and	  their	  protein	  targets	  in	  the	  skin.	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